azathioprine has been researched along with Pemphigus in 224 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Pemphigus: Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Introduction: To investigate the therapeutic efficacy of tacrolimus compared with azathioprine in the treatment of pemphigus vulgaris." | 9.20 | Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial. ( Baghernejhad, M; Dastgheib, L; Sadati, MS, 2015) |
| "The classic treatment for pemphigus vulgaris is prednisolone." | 9.17 | Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris. ( Akhyani, M; Balighi, K; Chams-Davatchi, C; Daneshpazhooh, M; Davatchi, F; Esmaili, N; Hallaji, Z; Mortazavi, H; Mortazavizadeh, A; Seirafi, H, 2013) |
| "A prospective, multicenter, randomized, nonblinded clinical trial to compare 2 parallel groups of patients with pemphigus (pemphigus vulgaris and pemphigus foliaceus) treated with oral methylprednisolone plus azathioprine or oral methylprednisolone plus mycophenolate mofetil." | 9.12 | A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. ( Beissert, S; Böhm, M; Frieling, U; Gollnick, H; Hunzelmann, N; Junghans, V; Luger, TA; Meurer, M; Pillekamp, H; Ruzicka, T; Rzany, B; Stadler, R; Sticherling, M; Werfel, T; Zillikens, D, 2006) |
| " In a multicenter, prospectively randomized study we compared efficacy and side effects of a dexamethasone-cyclophosphamide (D/C) pulse therapy with a methylprednisolone-azathioprine (M/A) therapy in 22 patients with newly diagnosed pemphigus vulgaris and pemphigus foliaceus." | 9.11 | Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study. ( Bröcker, EB; Haustein, UF; Linse, R; Rose, E; Wever, S; Zilliken, D, 2005) |
| " The control group consisted of seven patients with pemphigus who had received prednisone and azathioprine." | 9.09 | Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients. ( Calebotta, A; Carvalho, M; Castillo, R; González, F; Sáenz, AM, 1999) |
| "This retrospective study evaluates in which group of dogs [oclacitinib (OC) or azathioprine (AZ)] remission of pemphigus foliaceus (PF) was more effectively achieved with matched induction dosing of glucocorticoids; it further evaluates which group had a higher glucocorticoid-sparing effect." | 8.31 | The use of oclacitinib compared to azathioprine in the management of canine pemphigus foliaceus: A retrospective analysis. ( Bidot, WA; Griffin, CE; Hernandez-Bures, A; Rosenkrantz, WS, 2023) |
| "Azathioprine (AZA) is the preferred immunosuppressant for treating pemphigus vulgaris (PV), with discontinuation mainly attributed to hematological adverse events (AE)." | 8.12 | Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study. ( Cheng, L; Gou, H; Gu, Y; Ju, K; Lan, T; Li, G; Li, W; Sun, Y; Wang, Y; Xu, Y; Zhan, T; Zhou, X; Zhou, Y, 2022) |
| "Pemphigus vulgaris is a rare immune-mediated skin disorder of the dog, usually treated with immunosuppressive medications such as oral glucocorticoids, azathioprine or ciclosporin." | 8.12 | A case report of the beneficial effect of oclacitinib in a dog with pemphigus vulgaris. ( Crowley, A; Martinez, N; McDonald, B, 2022) |
| "Although azathioprine (AZA) combined with corticosteroids remains the first-line therapy to treat patients with pemphigus vulgaris (PV), there are increasing reports of AZA-induced leukopenia, which provides the rationale for monitoring the blood cell count and testing the genotypes at the thiopurine methyltransferase (TPMT) and the nucleoside diphosphate-linked moiety X-type motif 15 (NUDT15) genes." | 7.96 | Complete remission of refractory pemphigus vulgaris in a Chinese patient with mutated NUDT15 by combination of minimal doses of azathioprine and prednisone. ( Lan, TJ; Li, W; Shrestha, K; Zhan, TY; Zhou, XL; Zhou, YH, 2020) |
| " It has been previously shown in a relatively small group of patients that a combination of immunoadsorption (IA) and rituximab with daily use of high-dose oral corticosteroids and azathioprine/mycophenolate mofetil may induce a rapid and durable remission in severe, treatment-resistant pemphigus." | 7.78 | Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients. ( Kasperkiewicz, M; Kramer, J; Meier, M; Schmidt, E; Schumacher, N; Shimanovich, I; Westermann, L; Zillikens, D, 2012) |
| " low dose oral prednisone on alternate days plus azathioprine every day (Lever's mini treatment: LMT) in oral pemphigus." | 7.77 | High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study. ( Apalla, Z; Chaidemenos, G; Ioannides, D; Koussidou, T; Papagarifallou, I, 2011) |
| "To evaluate the relationship between thiopurine methyltransferase (TPMT) activity and the safety and efficacy of azathioprine sodium in the treatment of pemphigus vulgaris." | 7.74 | Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris. ( Chams-Davatchi, C; Firooz, A; Ghandi, N; Hallaji, Z; Karbakhsh Davari, M; Valikhani, M, 2008) |
| "To evaluate the efficacy and safety of prednisone as monotherapy and in combination with the three most popular adjuvant agents - azathioprine, cyclosporine (ciclosporin), and cyclophosphamide - in the treatment of pemphigus vulgaris." | 7.74 | Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris. ( Blaszczyk, M; Cwikla, J; Kolacinska-Strasz, Z; Labecka, H; Natorska, U; Olszewska, M; Sulej, J, 2007) |
| " The criteria for inclusion were the clinical diagnosis of pemphigus, confirmed by histological examination and direct immunofluorescence and first line therapy using the "Lever scheme" protocol, combining 40 mg of prednisone on alternate days and 100 mg/day of azathioprine." | 7.72 | [Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)]. ( Bedane, C; Benoit Corven, C; Carvalho, P; Chosidow, O; Joly, P; Noblesse, I; Prost, C; Roujeau, JC; Saiag, P; Verret, JL; Young, P, 2003) |
| "Azathioprine metabolism, to red cell 6-thioguanine nucleotides (6TGN), was studied in four patients with pemphigus vulgaris." | 7.67 | Metabolism of azathioprine to 6-thioguanine nucleotides in patients with pemphigus vulgaris. ( Harrington, CI; Lennard, L; Maddocks, JL; Wood, M, 1987) |
| "In a prospective long-term study, thirty-seven patients with severe generalized pemphigus vulgaris were treated with a combined corticosteroid-azathioprine regimen." | 7.67 | Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up. ( Aberer, W; Stingl, G; Wolff, K; Wolff-Schreiner, EC, 1987) |
| "2 women, 62 and 69 years old, both suffering from rheumatoid arthritis, were treated for 1 and 1 1/2 years, respectively, with penicillamine." | 7.66 | Two cases of penicillamine-induced pemphigus erythematosus. ( Thorvaldsen, J, 1979) |
| "Pemphigus is an autoimmune blistering mucocutaneous disorder." | 6.79 | Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris. ( Chams-Davatchi, C; Daneshpazhooh, M; Esmaili, N; Karimi, A; Mortazavi, H; Toosi, S; Valikhani, M, 2014) |
| "Sixteen patients affected by oral pemphigus vulgaris were retrospectively examined to illustrate the natural course of the disease and to describe the efficacy of the treatment we utilised." | 6.41 | Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases. ( Bucci, E; Carbone, R; Lo Muzio, L; Mignogna, MD; Mignogna, RE; Ruoppo, E, 2000) |
| "Rituximab is effective in treating pemphigus both as the first-line treatment and as an add-on treatment for refractory disease." | 5.56 | Maintenance therapy with azathioprine prolonged duration of remission for pemphigus patients who received rituximab as first-line or add-on therapy. ( Cho, YT; Chu, CY; Huang, YM; Wang, LF, 2020) |
| "Tacrolimus was well tolerated, and clinical improvement allowed tapering of corticosteroids." | 5.36 | Recalcitrant pemphigus vulgaris responding to systemic tacrolimus. ( Bruckner-Tuderman, L; Büsing, V; Hofmann, SC; Kern, JS, 2010) |
| "Pemphigus is an autoimmune blistering disease with high mortality if untreated." | 5.29 | Minocycline is a useful adjuvant therapy for pemphigus. ( Gaspar, ZS; Walkden, V; Wojnarowska, F, 1996) |
| "One week after treatment, diabetes mellitus was diagnosed on the basis of blood and urine test results." | 5.28 | Diabetes mellitus induced in a dog after administration of corticosteroids and methylprednisolone pulse therapy. ( Jeffers, JG; Schick, RO; Shanley, KJ, 1991) |
| "Dapsone was easily withdrawn at the onset of remission." | 5.27 | Use of cyclophosphamide in azathioprine failures in pemphigus. ( Ahmed, AR; Hombal, S, 1987) |
| "Introduction: To investigate the therapeutic efficacy of tacrolimus compared with azathioprine in the treatment of pemphigus vulgaris." | 5.20 | Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial. ( Baghernejhad, M; Dastgheib, L; Sadati, MS, 2015) |
| "The classic treatment for pemphigus vulgaris is prednisolone." | 5.17 | Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris. ( Akhyani, M; Balighi, K; Chams-Davatchi, C; Daneshpazhooh, M; Davatchi, F; Esmaili, N; Hallaji, Z; Mortazavi, H; Mortazavizadeh, A; Seirafi, H, 2013) |
| "A prospective, multicenter, randomized, nonblinded clinical trial to compare 2 parallel groups of patients with pemphigus (pemphigus vulgaris and pemphigus foliaceus) treated with oral methylprednisolone plus azathioprine or oral methylprednisolone plus mycophenolate mofetil." | 5.12 | A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. ( Beissert, S; Böhm, M; Frieling, U; Gollnick, H; Hunzelmann, N; Junghans, V; Luger, TA; Meurer, M; Pillekamp, H; Ruzicka, T; Rzany, B; Stadler, R; Sticherling, M; Werfel, T; Zillikens, D, 2006) |
| "The aim of this study was to compare the efficacy and safety of 4 treatment regimens for pemphigus vulgaris: prednisolone alone, prednisolone plus azathioprine, prednisolone plus mycophenolate mofetil, and prednisolone plus intravenous cyclophosphamide pulse therapy." | 5.12 | Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. ( Akhyani, M; Balighi, K; Barzegari, M; Chams-Davatchi, C; Daneshpazhooh, M; Esmaili, N; Ghodsi, SZ; Hallaji, Z; Mirshams-Shahshahani, M; Mortazavi, H; Nazemi, MJ; Seirafi, H; Valikhani, M, 2007) |
| " A patient with pemphigus vulgaris and myasthenia gravis was treated for approximately five years with the cholinomimetic Mestinon (pyridostigmine bromide), Imuran (azathioprine), and a topical corticosteroid gel before the need to introduce systemic glucocorticosteroids." | 5.11 | New approaches to the treatment of pemphigus. ( Grando, SA, 2004) |
| " In a multicenter, prospectively randomized study we compared efficacy and side effects of a dexamethasone-cyclophosphamide (D/C) pulse therapy with a methylprednisolone-azathioprine (M/A) therapy in 22 patients with newly diagnosed pemphigus vulgaris and pemphigus foliaceus." | 5.11 | Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study. ( Bröcker, EB; Haustein, UF; Linse, R; Rose, E; Wever, S; Zilliken, D, 2005) |
| " The control group consisted of seven patients with pemphigus who had received prednisone and azathioprine." | 5.09 | Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients. ( Calebotta, A; Carvalho, M; Castillo, R; González, F; Sáenz, AM, 1999) |
| "Patients with pemphigus vulgaris may occasionally present the highly active, widespread form of the disease, and/or maybe resistant to conventional oral steroid therapy, and/or manifest significant side effects from the prolonged use of high oral prednisone dosage." | 5.08 | Steroid-pulse therapy in pemphigus vulgaris long term follow-up. ( Chaidemenos, GC; Chryssomallis, F; Dimitriades, A; Karakatsanis, G; Panagiotides, D, 1995) |
| "Treatment of pemphigus is based on systemic glucocorticosteroids, frequently combined with potentially corticosteroid-sparing immunosuppressants such as azathioprine and mycophenolate mofetil/mycophenolic acid." | 5.01 | [Therapy of pemphigus]. ( Schmidt, E; van Beek, N; Zillikens, D, 2019) |
| "Preliminary data suggest a possible association between the use of azathioprine, cyclophosphamide, and cyclosporine and increased susceptibility to cancer in patients with pemphigus and pemphigoid." | 4.86 | Association between cancer and immunosuppressive therapy--analysis of selected studies in pemphigus and pemphigoid. ( Ahmed, AR; Christen, WG; Gürcan, HM; Keskin, DB; Mabrouk, D, 2010) |
| "To assess the risk of long-term cardiovascular and metabolic outcomes and all-cause mortality in patients with pemphigus managed by rituximab compared with those receiving treatment with first-line corticosteroid-sparing agents (azathioprine and mycophenolate mofetil [MMF])." | 4.31 | Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus. ( Kridin, K; Ludwig, RJ; Mruwat, N, 2023) |
| "This retrospective study evaluates in which group of dogs [oclacitinib (OC) or azathioprine (AZ)] remission of pemphigus foliaceus (PF) was more effectively achieved with matched induction dosing of glucocorticoids; it further evaluates which group had a higher glucocorticoid-sparing effect." | 4.31 | The use of oclacitinib compared to azathioprine in the management of canine pemphigus foliaceus: A retrospective analysis. ( Bidot, WA; Griffin, CE; Hernandez-Bures, A; Rosenkrantz, WS, 2023) |
| "Azathioprine (AZA) is the preferred immunosuppressant for treating pemphigus vulgaris (PV), with discontinuation mainly attributed to hematological adverse events (AE)." | 4.12 | Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study. ( Cheng, L; Gou, H; Gu, Y; Ju, K; Lan, T; Li, G; Li, W; Sun, Y; Wang, Y; Xu, Y; Zhan, T; Zhou, X; Zhou, Y, 2022) |
| "Pemphigus vulgaris is a rare immune-mediated skin disorder of the dog, usually treated with immunosuppressive medications such as oral glucocorticoids, azathioprine or ciclosporin." | 4.12 | A case report of the beneficial effect of oclacitinib in a dog with pemphigus vulgaris. ( Crowley, A; Martinez, N; McDonald, B, 2022) |
| "Although azathioprine (AZA) combined with corticosteroids remains the first-line therapy to treat patients with pemphigus vulgaris (PV), there are increasing reports of AZA-induced leukopenia, which provides the rationale for monitoring the blood cell count and testing the genotypes at the thiopurine methyltransferase (TPMT) and the nucleoside diphosphate-linked moiety X-type motif 15 (NUDT15) genes." | 3.96 | Complete remission of refractory pemphigus vulgaris in a Chinese patient with mutated NUDT15 by combination of minimal doses of azathioprine and prednisone. ( Lan, TJ; Li, W; Shrestha, K; Zhan, TY; Zhou, XL; Zhou, YH, 2020) |
| " It has been previously shown in a relatively small group of patients that a combination of immunoadsorption (IA) and rituximab with daily use of high-dose oral corticosteroids and azathioprine/mycophenolate mofetil may induce a rapid and durable remission in severe, treatment-resistant pemphigus." | 3.78 | Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients. ( Kasperkiewicz, M; Kramer, J; Meier, M; Schmidt, E; Schumacher, N; Shimanovich, I; Westermann, L; Zillikens, D, 2012) |
| " low dose oral prednisone on alternate days plus azathioprine every day (Lever's mini treatment: LMT) in oral pemphigus." | 3.77 | High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study. ( Apalla, Z; Chaidemenos, G; Ioannides, D; Koussidou, T; Papagarifallou, I, 2011) |
| " We are reporting a variant aplasia cutis congenita, which involved over 90% of the body surface area, which occurred in a baby born to a mother with pemphigus vulgaris who was on oral prednisolone and azathioprine." | 3.75 | Aplasia cutis congenita associated with azathioprine. ( Ali, S; Butt, UA; Ejaz, A; Iftikhar, N, 2009) |
| "A suggested protocol to treat pemphigus is presented." | 3.75 | Adjuvant therapy of pemphigus. ( Bystryn, JC, 1984) |
| "To evaluate the relationship between thiopurine methyltransferase (TPMT) activity and the safety and efficacy of azathioprine sodium in the treatment of pemphigus vulgaris." | 3.74 | Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris. ( Chams-Davatchi, C; Firooz, A; Ghandi, N; Hallaji, Z; Karbakhsh Davari, M; Valikhani, M, 2008) |
| "To evaluate the efficacy and safety of prednisone as monotherapy and in combination with the three most popular adjuvant agents - azathioprine, cyclosporine (ciclosporin), and cyclophosphamide - in the treatment of pemphigus vulgaris." | 3.74 | Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris. ( Blaszczyk, M; Cwikla, J; Kolacinska-Strasz, Z; Labecka, H; Natorska, U; Olszewska, M; Sulej, J, 2007) |
| "One hundred twenty-eight patients with pemphigus vulgaris, treated with prednisolone 2 mg/kg/day plus azathioprine 2 to 2." | 3.74 | Outcome of pemphigus vulgaris. ( Abedini, R; Chams-Davatchi, C; Daneshpazhooh, M; Farahani, F; Kavusi, S; Lajevardi, V, 2008) |
| " The criteria for inclusion were the clinical diagnosis of pemphigus, confirmed by histological examination and direct immunofluorescence and first line therapy using the "Lever scheme" protocol, combining 40 mg of prednisone on alternate days and 100 mg/day of azathioprine." | 3.72 | [Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)]. ( Bedane, C; Benoit Corven, C; Carvalho, P; Chosidow, O; Joly, P; Noblesse, I; Prost, C; Roujeau, JC; Saiag, P; Verret, JL; Young, P, 2003) |
| " We successfully treated a patient with pemphigus vulgaris with IVIG, after he had developed osteonecrosis of his right femoral head while on azathioprine and corticosteroids." | 3.72 | [Treatment of pemphigus vulgaris with high-dose intravenous immunoglobulins in a patient with steroid-induced osteonecrosis of the femoral head]. ( Enk, A; Giesecke, E; Kerstin, S, 2004) |
| "A 79-year-old female with pemphigus vulgaris developed a cytomegalovirus (CMV)-associated gastric ulcer whilst on standard immunosupression with azathioprine and prednisolone." | 3.71 | Cytomegalovirus-associated gastric ulcer in an immunosuppressed patient with pemphigus vulgaris. ( Orteu, CH; Orton, DI; Rustin, MH, 2001) |
| "To find out whether mycophenolate mofetil would be an effective drug in controlling pemphigus vulgaris in patients who failed initial treatment with azathioprine and prednisone." | 3.70 | Mycophenolate is effective in the treatment of pemphigus vulgaris. ( Enk, AH; Knop, J, 1999) |
| "All three patients with pemphigus vulgaris were treated with oral corticosteroid; in two cases, azathioprine was added for steroid-sparing effect." | 3.70 | Childhood pemphigus. ( Pongprasit, P; Wananukul, S, 1999) |
| "Azathioprine has an important role in treatment of many inflammatory dermatoses." | 3.69 | Azathioprine in dermatology: a survey of current practice in the U.K. ( English, JS; Gawkrodger, DJ; Lear, JT; Tan, BB, 1997) |
| "Pemphigus vulgaris is an uncommon auto-immune disease which responds well to treatment with corticosteroids and azathioprine." | 3.68 | Immunosuppressive therapy for pemphigus vulgaris complicated by malakoplakia of the bladder. ( Allen, FJ; Heyns, CF; Jordaan, HF; Schneider, J, 1990) |
| "Severe cases of pemphigus vulgaris should be treated with prednisone in high dosage (180-360 mg daily)." | 3.67 | [Therapy of pemphigus and pemphigoid]. ( Schaumburg-Lever, G, 1986) |
| "Azathioprine metabolism, to red cell 6-thioguanine nucleotides (6TGN), was studied in four patients with pemphigus vulgaris." | 3.67 | Metabolism of azathioprine to 6-thioguanine nucleotides in patients with pemphigus vulgaris. ( Harrington, CI; Lennard, L; Maddocks, JL; Wood, M, 1987) |
| "In a prospective long-term study, thirty-seven patients with severe generalized pemphigus vulgaris were treated with a combined corticosteroid-azathioprine regimen." | 3.67 | Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up. ( Aberer, W; Stingl, G; Wolff, K; Wolff-Schreiner, EC, 1987) |
| "2 women, 62 and 69 years old, both suffering from rheumatoid arthritis, were treated for 1 and 1 1/2 years, respectively, with penicillamine." | 3.66 | Two cases of penicillamine-induced pemphigus erythematosus. ( Thorvaldsen, J, 1979) |
| "A Mexican-American patient with pemphigus vulgaris developed fatal disseminated coccidioidomycosis while on immunosuppressive therapy with systemic corticosteroids and azathioprine." | 3.65 | Pemphigus vulgaris and disseminated coccidioidomycosis. ( Jacobs, PH; Krulig, L; Loeffel, D, 1976) |
| "Pemphigus is an autoimmune blistering mucocutaneous disorder." | 2.79 | Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris. ( Chams-Davatchi, C; Daneshpazhooh, M; Esmaili, N; Karimi, A; Mortazavi, H; Toosi, S; Valikhani, M, 2014) |
| "Corticosteroids are the systemic treatment of choice in patients with pemphigus vulgaris, but chronic administration is associated with side effects." | 2.74 | [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide]. ( Aguado, L; España Alonso, A; Fernández, S; Marquina, M; Panizo, C; Pretel, M; Sánchez-Ibarrola, A, 2009) |
| "In patients with new pemphigus vulgaris disease activity, there was no benefit of oral DP therapy given in addition to conventional treatment." | 2.72 | Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial. ( Cianchini, G; Jonkman, MF; Lambert, FP; Laseur, M; Mackenzie, MW; Mentink, LF; Pavlovic, MD; Tóth, GG; Veeger, NJ, 2006) |
| "Seventy-two patients of pemphigus (pemphigus vulgaris and severe cases of pemphigus vegetans, pemphigus foliaceous and pemphigus erythematosus) were divided into three groups." | 2.69 | Treatment of pemphigus: a local experience. ( Akhtar, SJ; Hasan, MU, 1998) |
| "Pemphigus is diagnosed on the basis of either IgG or complement component 3 deposits (or both) at the keratinocyte cell membrane, detected by direct immunofluorescence microscopy of a perilesional biopsy, with serum anti-Dsg1 or anti-Dsg3 antibodies (or both) detected by ELISA." | 2.61 | Pemphigus. ( Joly, P; Kasperkiewicz, M; Schmidt, E, 2019) |
| "All common treatments of pemphigus-azathioprine, mycophenolate mofetil, and methotrexate-should be avoided during pregnancy." | 2.55 | Management of pemphigus disease in pregnancy. ( Delshad, S; Mirsafaei, HS; Tavakolpour, S, 2017) |
| "Treatment modalities in pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are many and varied, although level 1 evidence supporting their use is limited." | 2.47 | Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus. ( Frew, JW; Martin, LK; Murrell, DF, 2011) |
| "Pemphigus vulgaris is an infrequent but life-threatening autoimmune blistering disease that is rare in the pediatric age." | 2.46 | Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature. ( Fuertes, I; Guilabert, A; Iranzo, P; Mascaró, JM, 2010) |
| "Prednisone was used in 37 of 49 (75%) patients with doses ranging from 5 to 300 mg/day (mean 152." | 2.45 | Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes. ( Ahmed, RA; Gürcan, HM; Kardos, M; Levine, D, 2009) |
| "The etiology of pemphigus vulgaris is still unknown, although the disease has attracted considerable interest." | 2.44 | Oral pemphigus vulgaris: a case report with review of the literature. ( Cakur, B; Dagistan, S; Goregen, M; Miloglu, O, 2008) |
| "Pemphigus is a group of potentially life-threatening autoimmune diseases characterized by cutaneous and/or mucosal blistering." | 2.43 | Number II. Pemphigus vulgaris. ( Black, M; Mignogna, MD; Scully, C, 2005) |
| "This paper describes a case of oral pemphigus vulgaris (PV) in a child that was diagnosed in its early stages and managed successfully." | 2.43 | Oral pemphigus vulgaris in children and adolescents: a review of the literature and a case report. ( Ariyawardana, A; Basnayake, LK; Dissanayake, M; Ranasinghe, AW; Sitheeque, MA; Tilakaratne, WM; Vitanaarachchi, N, 2005) |
| "Pemphigus is an autoimmune skin disease that can present in a variety of forms and can be a challenging disease to manage and treat." | 2.42 | Pemphigus: current therapy. ( Rosenkrantz, WS, 2004) |
| "Sixteen patients affected by oral pemphigus vulgaris were retrospectively examined to illustrate the natural course of the disease and to describe the efficacy of the treatment we utilised." | 2.41 | Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases. ( Bucci, E; Carbone, R; Lo Muzio, L; Mignogna, MD; Mignogna, RE; Ruoppo, E, 2000) |
| "Azathioprine has been available for 30 years and is used in a variety of dermatologic conditions." | 2.38 | Azathioprine in dermatology. ( Colver, GB; Harris, DW; Younger, IR, 1991) |
| "Azathioprine 50 mg orally was then used in place of dapsone due to rapid disease progression with extensive skin involvement." | 1.91 | Rescue treatment with intravenous immunoglobulin and amniotic membrane dressing in refractory paediatric pemphigus vulgaris with sepsis. ( Akham, R; Bhatia, R; Hazarika, N; Paonam, R, 2023) |
| "Rituximab treatment for pemphigus has only recently been introduced to the Israeli health basket." | 1.62 | Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience. ( Hodak, E; Leshem, YA; Levi, A; Mimouni, D; Snast, I; Spitzer, L, 2021) |
| "However, further progress in the treatment of pemphigus requires their validation." | 1.56 | Results of the guideline-based treatment for pemphigus: a single-centre experience with 84 cases. ( Amagai, M; Funakoshi, T; Kakuta, R; Kurihara, Y; Miyamoto, J; Tanikawa, A; Yamagami, J, 2020) |
| "Azathioprine was the most widely prescribed corticosteroid-sparing agent (in 22 patients)." | 1.56 | Pemphigus Vulgaris: A Retrospective Cohort Study of Clinical Features, Treatments, and Outcomes. ( Bollea Garlatti, ML; Cueto Sarmiento, KY; Cura, MJ; Mazzuoccolo, LD; Puga, MC; Riganti, J; Torre, AC, 2020) |
| "Pemphigus is a chronic, relapsing immunobullous disease." | 1.56 | Epidemiology and Factors Associated with Remission of Pemphigus Vulgaris and Foliaceus in Singapore. ( Cai, SC; Lim, YL; Tang, MB; Zhao, X, 2020) |
| "Rituximab is effective in treating pemphigus both as the first-line treatment and as an add-on treatment for refractory disease." | 1.56 | Maintenance therapy with azathioprine prolonged duration of remission for pemphigus patients who received rituximab as first-line or add-on therapy. ( Cho, YT; Chu, CY; Huang, YM; Wang, LF, 2020) |
| "CASE REPORT A 57-year-old man with pemphigus vulgaris was treated with steroids, non-steroidal anti-inflammatory drugs (NSAIDS), and azathioprine." | 1.51 | Recurrent Asymptomatic Sigmoid Diverticular Perforation in a Patient with Pemphigus Vulgaris on Immunosuppressive Therapy: A Case Report. ( Abboud, R; El Masri, A; Emmanuel, N; Fawaz, M; Haidar Ahmad, H; Hashem, M; Hussein, R; Nicolas, G; Rabah, H; Saliba, C; Sleiman, A, 2019) |
| " Rituximab has proven effective for the treatment of steroid-refractory pemphigus, although there is controversy over the optimum dosing protocol." | 1.48 | Low-dose rituximab and concurrent adjuvant therapy for pemphigus: Protocol and single-centre long-term review of nine patients. ( Robinson, AJ; Scardamaglia, L; Unglik, GA; Varigos, GA; Vu, M, 2018) |
| "Rituximab was the most effective of the three immunosuppressives for PV, although repeat dosing was frequently required." | 1.42 | Treatment outcomes in a cohort of patients with mucosal-predominant pemphigus vulgaris. ( Fulcher, DA; Lin, MW; O'Connor, K; Ojaimi, S; Schifter, M, 2015) |
| "Pemphigus is a worldwide disease and varies in its clinical profile and epidemiology in different regions of the world." | 1.38 | Epidemiology of pemphigus in the western region of Turkey: retrospective analysis of 87 patients. ( Bilgin, İ; Bozdag, K, 2012) |
| "We detected the presence of varicella zoster virus, as well as strong positivity for α-1 antitrypsin in the heart, kidneys, spleen, liver, skin, brain, lungs, pancreas, small and large intestines, and skeletal muscle." | 1.38 | Varicella-zoster virus (VZV) and alpha 1 antitrypsin: a fatal outcome in a patient affected by endemic pemphigus foliaceus. ( Abreu Velez, AM; Arias, LF; Dudley, SC; Gao, W; Grossniklaus, HE; Howard, MS; Jiao, Z; Smoller, BR, 2012) |
| "We report three adolescents with pemphigus vulgaris whose disease started at the age of 13, 15 and 14 years, respectively." | 1.37 | Pemphigus vulgaris in three adolescents: the course of the disease. ( Djakovic, Z; Medenica, L; Nikolic, M; Popadic, S; Skiljevic, D, 2011) |
| "Pemphigus is the most common and severe autoimmune bullous disease in Korea." | 1.37 | Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients. ( Kim, HC; Kim, MR; Kim, SC, 2011) |
| "Tacrolimus was well tolerated, and clinical improvement allowed tapering of corticosteroids." | 1.36 | Recalcitrant pemphigus vulgaris responding to systemic tacrolimus. ( Bruckner-Tuderman, L; Büsing, V; Hofmann, SC; Kern, JS, 2010) |
| "Pemphigus is a serious, potentially fatal chronic autoimmune bullous disease with cutaneous and mucosal manifestations." | 1.35 | [Epidemiology of pemphigus in the Hospital Universitario Virgen Macarena, Seville, Spain, 2005-2006]. ( Camacho, FM; Coronel-Pérez, IM; Pérez-Bernal, AM; Rodríguez-Rey, EM, 2009) |
| "Seventy patients with pemphigus vulgaris, treated with a uniform protocol, were enrolled." | 1.35 | Impact of smoking on pemphigus. ( Chams-Davatchi, C; Esmaili, N; Farahani, F; Ghandi, N; Hallaji, Z; Kavusi, S; Lajevardi, V; Valikhani, M, 2008) |
| "Pemphigus is a rare and chronic life-threatening disease." | 1.33 | Pemphigus: analysis of 1209 cases. ( Akhiani, M; Balighi, K; Barzegari, M; Chams-Davatchi, C; Daneshpazhooh, M; Esmaili, N; Ghodsi, Z; Hallaji, Z; Mortazavi, H; Naraghi, Z; Valikhani, M, 2005) |
| "An association of pemphigus vulgaris with vitiligo or Hashimoto's thyroiditis has not been reported before." | 1.33 | Development of pemphigus vulgaris in a patient with vitiligo and Hashimoto's thyroiditis. ( Alli, N; Oztas, P; Tamer, E; Toy, GG; Yalçin, B, 2005) |
| "Pemphigus vulgaris is the commonest clinical type." | 1.33 | Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases. ( Garg, G; Mahajan, VK; Sharma, NL; Sharma, RC, 2005) |
| "Juvenile pemphigus vulgaris (JPV) is a rare autoimmune disease." | 1.33 | [Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulins]. ( Buchvald, D; Danilla, T; Szép, Z, 2005) |
| "Treatment with prednisolone and azathioprine caused rapid and complete healing." | 1.33 | [Desmoglein 1-negative, desmoglein 3-positive pemphigus herpetiformis with involvement of oral mucous membranes]. ( Brod, C; Fierlbeck, G; Metzler, G; Röcken, M; Schaller, M; Sönnichsen, K, 2005) |
| "Pemphigus is a disease demonstrating an uneven geographic distribution." | 1.33 | Epidemiology of pemphigus in south-western Iran: a 10-year retrospective study (1991-2000). ( Namazi, MR; Rahman-Shenas, MR; Salmanpour, R; Shahkar, H, 2006) |
| "Esophageal involvement of pemphigus vulgaris (PV) had been considered an exceptional event." | 1.33 | Involvement of the esophagus in a patient with pemphigus vulgaris who was on immunosuppressive therapy. ( Boyacioglu, S; Gur, G; Kanbay, M; Selcuk, H; Yilmaz, U, 2006) |
| "The pemphigus vulgaris is a serious bullous disease of the adult." | 1.33 | [Laryngeal pemphigus]. ( Charpy, N; Franck, N; Lecanu, JB; Pelisse, M, 2006) |
| " For the treatment of pemphigus, a course of the lowest possible corticosteroid dosage in combination with immunosuppressive agents appears to be effective and less toxic than a high corticosteroid dosage." | 1.32 | Pemphigus in Korea: clinical manifestations and treatment protocol. ( Choi, WW; Chung, JH; Seo, PG, 2003) |
| "We report this case of pemphigus vulgaris with unusual clinical aspects, namely vegetating and verrucous lesions as well as nail involvement, rarely described in this disease." | 1.32 | Pemphigus vulgaris with nail involvement presenting with vegetating and verrucous lesions. ( Fernandes, B; Figueiredo, A; Mascarenhas, R; Reis, JP; Tellechea, O, 2003) |
| "Pemphigus vulgaris is an autoimmune blistering disorder in which both genetic and environmental factors, mainly drugs, are thought to play a part in its aetiopathogenesis." | 1.31 | A case of pemphigus vulgaris possibly triggered by quinolones. ( Anadolu, RY; Birol, A; Bostanci, S; Boyvatt, A, 2002) |
| "Although pemphigus is a well-characterized entity, detailed epidemiologic studies from the Arabian Peninsula are not available." | 1.30 | Pemphigus in Kuwait. ( Al-Baghli, NM; Alsaleh, QA; Dvorak, R; Nanda, A, 1999) |
| "Recurrence was observed in 2 cases." | 1.30 | [Herpetic superinfection of pemphigus: 6 cases]. ( Azzouzi, S; el Ouazzani, T; Lakhdar, H; Sqalli, S; Zouhair, K, 1999) |
| "Pemphigus is an autoimmune blistering disease with high mortality if untreated." | 1.29 | Minocycline is a useful adjuvant therapy for pemphigus. ( Gaspar, ZS; Walkden, V; Wojnarowska, F, 1996) |
| "The conjunctiva later became scarred with foreshortening of the fornices and development of symblepharon." | 1.28 | Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma. ( Folberg, R; Goeken, JA; Krachmer, JH; Lam, S; Massicotte, SJ; Smith, AC; Stone, MS, 1992) |
| "One week after treatment, diabetes mellitus was diagnosed on the basis of blood and urine test results." | 1.28 | Diabetes mellitus induced in a dog after administration of corticosteroids and methylprednisolone pulse therapy. ( Jeffers, JG; Schick, RO; Shanley, KJ, 1991) |
| "Two cases of pemphigus vulgaris in which oral lesions were the first signs of the disease are reported." | 1.28 | Pemphigus vulgaris of the oral mucosa: report of two cases. ( Brouwer, TJ; Raghoebar, GM; Schoots, CJ, 1991) |
| "Dapsone is a helpful adjuvant to therapy." | 1.27 | Juvenile pemphigus. ( Ahmed, AR; Salm, M, 1983) |
| "We describe three patients with pemphigus vulgaris, who during treatment with low doses of immunosuppressive drugs developed persistent keratotic or vegetating skin lesions." | 1.27 | Persistent vegetating and keratotic lesions in patients with pemphigus vulgaris during immunosuppressive therapy. ( Faber, WR; Flinterman, J; Neumann, HA, 1983) |
| " The mean initial steroid dosage was 87 mg prednisone equivalent per day." | 1.27 | [Therapy of pemphigus. Critical remarks based on 44 clinical cases]. ( Smolle, J, 1985) |
| " Its implication for the dosage of steroids is opposite that in steroid-induced peptic ulcers." | 1.27 | Oesophageal pemphigus vulgaris. ( Al Karawi, M; Coode, P; Mobacken, H; Mohamed, A, 1988) |
| "Dapsone was easily withdrawn at the onset of remission." | 1.27 | Use of cyclophosphamide in azathioprine failures in pemphigus. ( Ahmed, AR; Hombal, S, 1987) |
| "Treatment with prednisone and azathioprine resulted in the disappearance of vetetating lesions and in healing, with postinflammatory hyperpigmentation." | 1.26 | Pyodermite végétante of Hallopeau. Immunofluorescence studies performed in an early disease stage. ( Faber, WR; Neumann, HA, 1980) |
| " In pemphigus erythematosus, very good results were obtained in 3 of 5 cases, and failure in 2 cases was probably related to insufficient dosage of steroids, or no treatment with steroids at all." | 1.25 | Visken as supplementary drug in the treatment of pemphigus. ( Blaszczyk, M; Chorzelski, T; Jablonska, S; Maciejowska, E, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 66 (29.46) | 18.7374 |
| 1990's | 33 (14.73) | 18.2507 |
| 2000's | 57 (25.45) | 29.6817 |
| 2010's | 45 (20.09) | 24.3611 |
| 2020's | 23 (10.27) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, X | 1 |
| Cheng, L | 1 |
| Wang, Y | 1 |
| Gou, H | 1 |
| Ju, K | 1 |
| Lan, T | 1 |
| Zhan, T | 1 |
| Li, G | 1 |
| Gu, Y | 1 |
| Sun, Y | 2 |
| Xu, Y | 1 |
| Zhou, Y | 1 |
| Li, W | 3 |
| Somerville, E | 1 |
| Gebauer, K | 1 |
| Mclean-Tooke, A | 1 |
| Martinez, N | 1 |
| McDonald, B | 1 |
| Crowley, A | 1 |
| Kaae, J | 1 |
| Bech, R | 1 |
| Taudorf, EH | 1 |
| Beck, S | 1 |
| Vestergaard, C | 1 |
| Ring, HC | 1 |
| Jemec, GB | 1 |
| Kridin, K | 4 |
| Mruwat, N | 4 |
| Ludwig, RJ | 4 |
| Cazzaniga, S | 1 |
| Naldi, L | 1 |
| Borradori, L | 1 |
| Amber, KT | 1 |
| Irrera, M | 1 |
| Bozzola, E | 1 |
| Cardoni, A | 1 |
| DeVito, R | 1 |
| Diociaiuti, A | 1 |
| El Hachem, M | 1 |
| Girardi, K | 1 |
| Marchesi, A | 1 |
| Villani, A | 1 |
| Akham, R | 1 |
| Bhatia, R | 1 |
| Paonam, R | 1 |
| Hazarika, N | 1 |
| Hernandez-Bures, A | 1 |
| Bidot, WA | 1 |
| Griffin, CE | 1 |
| Rosenkrantz, WS | 2 |
| Hayashi, W | 1 |
| Adachi, A | 1 |
| Naito, A | 1 |
| Suzuki, M | 1 |
| Sawada, Y | 1 |
| Maljić, J | 1 |
| Radoš, J | 1 |
| Lončarić, D | 1 |
| Lakoš Jukić, I | 1 |
| Kussini, J | 1 |
| Kaisers, T | 1 |
| Sequeira Santos, AM | 1 |
| Eming, R | 1 |
| Didona, D | 1 |
| Gheisari, M | 1 |
| Faraji, Z | 1 |
| Dadras, MS | 1 |
| Nasiri, S | 1 |
| Robati, RM | 1 |
| Moravvej, H | 1 |
| Tehranchinia, Z | 1 |
| Ghalamkarpour, F | 1 |
| Namazi, N | 1 |
| Nobari, NN | 1 |
| Schmidt, E | 4 |
| Kasperkiewicz, M | 2 |
| Joly, P | 2 |
| Kakuta, R | 2 |
| Kurihara, Y | 1 |
| Yamagami, J | 2 |
| Miyamoto, J | 1 |
| Funakoshi, T | 2 |
| Tanikawa, A | 1 |
| Amagai, M | 3 |
| Kim, WI | 1 |
| Park, TH | 1 |
| Yoon, SY | 1 |
| Whang, KU | 1 |
| Cho, MK | 1 |
| Kim, S | 3 |
| Cura, MJ | 1 |
| Torre, AC | 1 |
| Cueto Sarmiento, KY | 1 |
| Bollea Garlatti, ML | 1 |
| Riganti, J | 1 |
| Puga, MC | 1 |
| Mazzuoccolo, LD | 1 |
| Chen, A | 1 |
| Yoshizaki, A | 1 |
| Miyagaki, T | 1 |
| Streilein, RD | 1 |
| Tedder, TF | 1 |
| Hall, RP | 1 |
| Cai, SC | 1 |
| Zhao, X | 1 |
| Tang, MB | 1 |
| Lim, YL | 2 |
| Zhou, XL | 1 |
| Zhan, TY | 1 |
| Zhou, YH | 2 |
| Shrestha, K | 1 |
| Lan, TJ | 1 |
| Snast, I | 1 |
| Spitzer, L | 1 |
| Hodak, E | 2 |
| Levi, A | 1 |
| Mimouni, D | 3 |
| Leshem, YA | 2 |
| Lee, MS | 1 |
| Yeh, YC | 1 |
| Tu, YK | 1 |
| Chan, TC | 1 |
| Yun, T | 1 |
| Koo, Y | 1 |
| Kim, H | 1 |
| Kang, JH | 1 |
| Yang, MP | 1 |
| Kang, BT | 1 |
| Kumar, S | 1 |
| De, D | 1 |
| Handa, S | 1 |
| Ratho, RK | 1 |
| Bhandari, S | 1 |
| Pal, A | 1 |
| Kamboj, P | 1 |
| Sarkar, S | 1 |
| Yan, W | 1 |
| Wang, L | 1 |
| Xiao, J | 1 |
| Takahashi, H | 1 |
| Ohyama, M | 1 |
| Stojković-Filipović, J | 1 |
| Lekić, B | 1 |
| Milčić, D | 1 |
| Milinković, MV | 1 |
| Tay, YE | 1 |
| Lee, SSJ | 1 |
| Fujimoto, N | 1 |
| Matsuo, S | 1 |
| Satoh, T | 1 |
| Shih, YC | 1 |
| Zou, YR | 1 |
| Wang, B | 1 |
| Zheng, J | 1 |
| Pan, M | 1 |
| Inaoki, M | 1 |
| Oishi, K | 1 |
| Nishijima, C | 1 |
| Takehara, K | 1 |
| Ishii, K | 1 |
| Gómez Moyano, E | 1 |
| Ayala Blanca, M | 1 |
| Martínez Pilar, L | 1 |
| Tang, HJ | 1 |
| Lai, CC | 1 |
| Lai, FJ | 1 |
| Li, SY | 1 |
| Liang, HY | 1 |
| Hsueh, PR | 1 |
| van Beek, N | 1 |
| Zillikens, D | 4 |
| Cho, YT | 1 |
| Huang, YM | 1 |
| Wang, LF | 1 |
| Chu, CY | 1 |
| Saliba, C | 1 |
| Rabah, H | 1 |
| Nicolas, G | 1 |
| Emmanuel, N | 1 |
| Sleiman, A | 1 |
| Hashem, M | 1 |
| Hussein, R | 1 |
| El Masri, A | 1 |
| Abboud, R | 1 |
| Fawaz, M | 1 |
| Haidar Ahmad, H | 1 |
| Walker, SL | 1 |
| Mann, TA | 1 |
| Dastgheib, L | 1 |
| Sadati, MS | 1 |
| Baghernejhad, M | 1 |
| Gdalevich, M | 1 |
| Ziv, M | 1 |
| David, M | 3 |
| Esmaili, N | 5 |
| Chams-Davatchi, C | 7 |
| Valikhani, M | 5 |
| Daneshpazhooh, M | 6 |
| Toosi, S | 2 |
| Karimi, A | 1 |
| Mortazavi, H | 5 |
| Kurtzman, DJ | 1 |
| Christopher, M | 1 |
| Lian, F | 1 |
| Sligh, JE | 1 |
| Ojaimi, S | 1 |
| O'Connor, K | 1 |
| Lin, MW | 1 |
| Schifter, M | 1 |
| Fulcher, DA | 1 |
| Gissi, DB | 1 |
| Tarsitano, A | 1 |
| Baldovini, C | 1 |
| Gabusi, A | 1 |
| Tavakolpour, S | 1 |
| Mirsafaei, HS | 1 |
| Delshad, S | 1 |
| Robinson, AJ | 1 |
| Vu, M | 1 |
| Unglik, GA | 1 |
| Varigos, GA | 1 |
| Scardamaglia, L | 1 |
| Lo Schiavo, A | 1 |
| Sangiuliano, S | 1 |
| Puca, RV | 1 |
| Brunetti, G | 1 |
| Ruocco, E | 1 |
| Cozzi, R | 1 |
| Takae, Y | 1 |
| Nishikawa, T | 1 |
| Firooz, A | 2 |
| Ghandi, N | 2 |
| Hallaji, Z | 6 |
| Karbakhsh Davari, M | 1 |
| Demitsu, T | 1 |
| Kakurai, M | 1 |
| Azuma, R | 1 |
| Hiratsuka, Y | 1 |
| Yamada, T | 1 |
| Yoneda, K | 1 |
| Dagistan, S | 1 |
| Goregen, M | 1 |
| Miloglu, O | 1 |
| Cakur, B | 1 |
| España Alonso, A | 1 |
| Panizo, C | 1 |
| Fernández, S | 2 |
| Marquina, M | 1 |
| Pretel, M | 1 |
| Aguado, L | 1 |
| Sánchez-Ibarrola, A | 1 |
| Coronel-Pérez, IM | 1 |
| Rodríguez-Rey, EM | 1 |
| Pérez-Bernal, AM | 1 |
| Camacho, FM | 1 |
| el-Azhary, RA | 1 |
| Farmer, SA | 1 |
| Drage, LA | 1 |
| Rogers, RS | 1 |
| McEvoy, MT | 1 |
| Davis, MD | 1 |
| Bridges, AG | 1 |
| Gibson, LE | 1 |
| Recke, A | 1 |
| Rose, C | 1 |
| Bröcker, EB | 2 |
| Sitaru, C | 1 |
| Kardos, M | 1 |
| Levine, D | 1 |
| Gürcan, HM | 2 |
| Ahmed, RA | 1 |
| Iftikhar, N | 1 |
| Ejaz, A | 1 |
| Butt, UA | 1 |
| Ali, S | 1 |
| Fuertes, I | 1 |
| Guilabert, A | 1 |
| Mascaró, JM | 1 |
| Iranzo, P | 1 |
| Menezes, N | 1 |
| Leite, I | 1 |
| Tente, D | 1 |
| Couceiro, A | 1 |
| Baptista, A | 1 |
| Varela, P | 1 |
| Azira, NM | 1 |
| Zeehaida, M | 1 |
| Chaidemenos, G | 1 |
| Apalla, Z | 1 |
| Koussidou, T | 3 |
| Papagarifallou, I | 1 |
| Ioannides, D | 1 |
| Büsing, V | 1 |
| Kern, JS | 1 |
| Bruckner-Tuderman, L | 1 |
| Hofmann, SC | 1 |
| Lolis, M | 1 |
| Czernik, A | 1 |
| Bystryn, JC | 5 |
| Mabrouk, D | 1 |
| Keskin, DB | 1 |
| Christen, WG | 1 |
| Ahmed, AR | 4 |
| Martin, LK | 2 |
| Werth, VP | 1 |
| Villaneuva, EV | 1 |
| Murrell, DF | 3 |
| Popadic, S | 1 |
| Medenica, L | 1 |
| Skiljevic, D | 1 |
| Djakovic, Z | 1 |
| Nikolic, M | 1 |
| Shimanovich, I | 1 |
| Meier, M | 1 |
| Schumacher, N | 1 |
| Westermann, L | 1 |
| Kramer, J | 1 |
| Mylonakis, E | 1 |
| Muse, VV | 1 |
| Mino-Kenudson, M | 1 |
| Frew, JW | 2 |
| Kim, MR | 1 |
| Kim, HC | 1 |
| Kim, SC | 2 |
| Babaeijandaghi, F | 1 |
| Akbarzadeh, M | 1 |
| Rezaei, N | 1 |
| Amirzargar, AA | 1 |
| Jalali, A | 1 |
| Wafa, A | 1 |
| Hicham, H | 1 |
| Yassir, A | 1 |
| Zoubida, TM | 1 |
| Mohamed, A | 3 |
| Amine, H | 1 |
| Abdelaziz, M | 1 |
| Bozdag, K | 1 |
| Bilgin, İ | 1 |
| Gharote, HP | 1 |
| Nair, PP | 1 |
| Kasetty, S | 1 |
| Thomas, S | 1 |
| Kulkarni, A | 1 |
| Abreu Velez, AM | 1 |
| Smoller, BR | 1 |
| Gao, W | 1 |
| Grossniklaus, HE | 1 |
| Jiao, Z | 1 |
| Arias, LF | 1 |
| Dudley, SC | 1 |
| Howard, MS | 1 |
| España, A | 1 |
| Navedo, M | 1 |
| Barona, L | 1 |
| Heng, YK | 1 |
| Lee, JS | 1 |
| Neoh, CY | 1 |
| Mortazavizadeh, A | 1 |
| Davatchi, F | 1 |
| Balighi, K | 3 |
| Akhyani, M | 2 |
| Seirafi, H | 2 |
| Verrini, A | 1 |
| Cannata, G | 1 |
| Cozzani, E | 1 |
| Terracini, M | 1 |
| Parodi, A | 1 |
| Rebora, A | 1 |
| Benoit Corven, C | 1 |
| Carvalho, P | 1 |
| Prost, C | 1 |
| Verret, JL | 1 |
| Saiag, P | 1 |
| Noblesse, I | 1 |
| Bedane, C | 1 |
| Chosidow, O | 2 |
| Young, P | 1 |
| Roujeau, JC | 1 |
| Ikeda, S | 1 |
| Komiyama, E | 1 |
| Ogawa, H | 2 |
| Nousari, CH | 1 |
| Cummins, DL | 1 |
| Kouba, DJ | 1 |
| Anhalt, GJ | 2 |
| Seo, PG | 1 |
| Choi, WW | 1 |
| Chung, JH | 1 |
| Gupta, MT | 1 |
| Jerajani, HR | 1 |
| Grando, SA | 1 |
| Mascarenhas, R | 1 |
| Fernandes, B | 1 |
| Reis, JP | 1 |
| Tellechea, O | 1 |
| Figueiredo, A | 1 |
| Renkl, A | 1 |
| Mockenhaupt, M | 1 |
| Technau, K | 1 |
| Herouy, Y | 1 |
| Norgauer, J | 1 |
| Olivry, T | 1 |
| Bergvall, KE | 1 |
| Atlee, BA | 1 |
| Cunha, PR | 1 |
| de Oliveira, JR | 1 |
| Salles, MJ | 1 |
| Jamora, J | 1 |
| del Pozo, J | 1 |
| Martínez, W | 1 |
| Carro, E | 1 |
| Arévalo, MP | 1 |
| Rodríguez-Lozano, J | 1 |
| Fonseca, E | 1 |
| Rossum, MM | 1 |
| Verhaegen, NT | 1 |
| Jonkman, MF | 4 |
| Mackenzie, MA | 1 |
| Koster, A | 1 |
| Van Der Valk, PG | 1 |
| Span, LF | 1 |
| Lee, HE | 1 |
| Wong, WR | 1 |
| Lee, MC | 1 |
| Hong, HS | 1 |
| Black, M | 1 |
| Mignogna, MD | 2 |
| Scully, C | 1 |
| Barzegari, M | 2 |
| Akhiani, M | 1 |
| Ghodsi, Z | 1 |
| Naraghi, Z | 1 |
| Ariyawardana, A | 1 |
| Tilakaratne, WM | 1 |
| Dissanayake, M | 1 |
| Vitanaarachchi, N | 1 |
| Basnayake, LK | 1 |
| Sitheeque, MA | 1 |
| Ranasinghe, AW | 1 |
| Yalçin, B | 1 |
| Tamer, E | 1 |
| Toy, GG | 1 |
| Oztas, P | 1 |
| Alli, N | 1 |
| Mahajan, VK | 1 |
| Sharma, NL | 1 |
| Sharma, RC | 1 |
| Garg, G | 1 |
| Szép, Z | 1 |
| Danilla, T | 1 |
| Buchvald, D | 1 |
| Giesecke, E | 1 |
| Enk, A | 1 |
| Kerstin, S | 1 |
| Brod, C | 1 |
| Fierlbeck, G | 2 |
| Metzler, G | 1 |
| Sönnichsen, K | 1 |
| Röcken, M | 2 |
| Schaller, M | 2 |
| Rose, E | 1 |
| Wever, S | 1 |
| Zilliken, D | 1 |
| Linse, R | 1 |
| Haustein, UF | 2 |
| Salmanpour, R | 1 |
| Shahkar, H | 1 |
| Namazi, MR | 1 |
| Rahman-Shenas, MR | 1 |
| Park, SG | 1 |
| Chang, JY | 1 |
| Cho, YH | 1 |
| Lee, MG | 1 |
| Mentink, LF | 1 |
| Mackenzie, MW | 1 |
| Tóth, GG | 1 |
| Laseur, M | 1 |
| Lambert, FP | 1 |
| Veeger, NJ | 1 |
| Cianchini, G | 1 |
| Pavlovic, MD | 1 |
| Kanbay, M | 1 |
| Selcuk, H | 1 |
| Gur, G | 1 |
| Yilmaz, U | 1 |
| Boyacioglu, S | 1 |
| Beissert, S | 1 |
| Werfel, T | 1 |
| Frieling, U | 1 |
| Böhm, M | 1 |
| Sticherling, M | 1 |
| Stadler, R | 1 |
| Rzany, B | 1 |
| Hunzelmann, N | 1 |
| Meurer, M | 1 |
| Gollnick, H | 1 |
| Ruzicka, T | 1 |
| Pillekamp, H | 1 |
| Junghans, V | 1 |
| Luger, TA | 1 |
| Samadi, Z | 1 |
| Gorouhi, F | 1 |
| Davari, P | 1 |
| Charpy, N | 1 |
| Franck, N | 1 |
| Lecanu, JB | 1 |
| Pelisse, M | 1 |
| Olszewska, M | 1 |
| Kolacinska-Strasz, Z | 1 |
| Sulej, J | 1 |
| Labecka, H | 1 |
| Cwikla, J | 1 |
| Natorska, U | 1 |
| Blaszczyk, M | 3 |
| Kaiser, J | 1 |
| Kaatz, M | 1 |
| Elsner, P | 1 |
| Ziemer, M | 1 |
| Ghodsi, SZ | 1 |
| Nazemi, MJ | 1 |
| Mirshams-Shahshahani, M | 1 |
| Chaidemenos, GCh | 1 |
| Mourellou, O | 2 |
| Tsatsou, F | 1 |
| Kavusi, S | 2 |
| Farahani, F | 2 |
| Abedini, R | 1 |
| Lajevardi, V | 2 |
| Weger, W | 1 |
| Aberer, E | 1 |
| Guenova, E | 1 |
| Hoetzenecker, W | 1 |
| Bailin, PL | 1 |
| Matkaluk, RM | 1 |
| Salm, M | 1 |
| Katz, M | 1 |
| Holubar, K | 3 |
| Lynde, CW | 1 |
| Ongley, RC | 1 |
| Rigg, JM | 1 |
| Vennemann, F | 1 |
| Schedel, A | 1 |
| Lorenzen, M | 1 |
| Faber, WR | 2 |
| Neumann, HA | 2 |
| Flinterman, J | 1 |
| Lever, WF | 2 |
| Schaumburg-Lever, G | 3 |
| Gendler, E | 1 |
| Levene, GM | 1 |
| Moy, R | 1 |
| Coverton, RW | 1 |
| Armstrong, RB | 1 |
| Chryssomallis, F | 1 |
| Dimitriades, A | 1 |
| Chaidemenos, GC | 2 |
| Panagiotides, D | 1 |
| Karakatsanis, G | 1 |
| Kapetis, E | 1 |
| Schaller, J | 1 |
| Rohwedder, A | 1 |
| Breier, B | 1 |
| Werchau, H | 1 |
| Pandhi, RK | 1 |
| Gupta, LK | 1 |
| Girdhar, M | 1 |
| Paterson, AJ | 1 |
| Lamey, PJ | 2 |
| Lewis, MA | 1 |
| Nolan, A | 1 |
| Rademaker, M | 1 |
| Huilgol, SC | 1 |
| Black, MM | 1 |
| Steinman, NM | 1 |
| Plumb, R | 1 |
| Doolittle, GC | 1 |
| Gaspar, ZS | 1 |
| Walkden, V | 1 |
| Wojnarowska, F | 1 |
| Jackson, AP | 1 |
| Hall, AG | 1 |
| McLelland, J | 1 |
| Tan, BB | 1 |
| Lear, JT | 1 |
| Gawkrodger, DJ | 1 |
| English, JS | 1 |
| Thakur, BK | 1 |
| Bernardi, DM | 1 |
| Murali, MR | 1 |
| McClain, SA | 1 |
| Clark, RA | 1 |
| Enk, AH | 1 |
| Knop, J | 1 |
| van der Waal, RI | 1 |
| Pas, HH | 1 |
| Schulten, EA | 1 |
| Nieboer, C | 1 |
| Wananukul, S | 1 |
| Pongprasit, P | 1 |
| Akhtar, SJ | 1 |
| Hasan, MU | 1 |
| Calebotta, A | 1 |
| Sáenz, AM | 1 |
| González, F | 1 |
| Carvalho, M | 1 |
| Castillo, R | 1 |
| Alsaleh, QA | 1 |
| Nanda, A | 1 |
| Al-Baghli, NM | 1 |
| Dvorak, R | 1 |
| Zouhair, K | 1 |
| el Ouazzani, T | 1 |
| Azzouzi, S | 1 |
| Sqalli, S | 1 |
| Lakhdar, H | 1 |
| Lo Muzio, L | 1 |
| Mignogna, RE | 1 |
| Carbone, R | 1 |
| Ruoppo, E | 1 |
| Bucci, E | 1 |
| Sirois, D | 1 |
| Leigh, JE | 1 |
| Sollecito, TP | 1 |
| Elston, DM | 1 |
| Epstein, JB | 1 |
| Gorsky, M | 1 |
| Epstein, MS | 1 |
| Nantel, S | 1 |
| Orton, DI | 1 |
| Orteu, CH | 1 |
| Rustin, MH | 1 |
| Anadolu, RY | 1 |
| Birol, A | 1 |
| Bostanci, S | 1 |
| Boyvatt, A | 1 |
| Schulze, P | 1 |
| Thorvaldsen, J | 1 |
| Turkevich, IuM | 1 |
| Fellner, MJ | 1 |
| Katz, JM | 1 |
| McCabe, JB | 1 |
| Jauregui, HO | 1 |
| Pehamberger, H | 1 |
| Pateisky, K | 1 |
| Walker, AE | 1 |
| Gervasini, A | 1 |
| Kötteritz, H | 1 |
| Tappeiner, J | 1 |
| Lynch, PJ | 1 |
| Gallego, RE | 1 |
| Saied, NK | 1 |
| Rancourt, J | 1 |
| Lassonde, M | 1 |
| Chorzelski, T | 2 |
| Jablonska, S | 3 |
| Maciejowska, E | 1 |
| Krulig, L | 1 |
| Jacobs, PH | 1 |
| Loeffel, D | 1 |
| Hymes, SR | 1 |
| Jordon, RE | 3 |
| Rees, TD | 1 |
| Binnie, WH | 1 |
| Wright, JM | 1 |
| Rankin, KV | 1 |
| Simpson, NB | 1 |
| Lam, S | 1 |
| Stone, MS | 1 |
| Goeken, JA | 1 |
| Massicotte, SJ | 1 |
| Smith, AC | 1 |
| Folberg, R | 1 |
| Krachmer, JH | 1 |
| Jeffers, JG | 1 |
| Shanley, KJ | 1 |
| Schick, RO | 1 |
| Younger, IR | 1 |
| Harris, DW | 1 |
| Colver, GB | 1 |
| Goodyear, HM | 1 |
| Abrahamson, EL | 1 |
| Harper, JI | 1 |
| Bourgeois-Droin, C | 1 |
| Granier, F | 1 |
| Pedreiro, J | 1 |
| Madinier, V | 1 |
| Grossin, M | 2 |
| Firth, N | 1 |
| Rich, A | 1 |
| Varigos, G | 1 |
| Reade, PC | 1 |
| Raghoebar, GM | 1 |
| Brouwer, TJ | 1 |
| Schoots, CJ | 1 |
| Murdock, DK | 1 |
| Lookingbill, DP | 1 |
| Yoshiike, K | 1 |
| Shiozawa, E | 1 |
| Yamada, H | 1 |
| Taneda, A | 1 |
| Takamori, K | 1 |
| Jordaan, HF | 1 |
| Heyns, CF | 1 |
| Allen, FJ | 1 |
| Schneider, J | 1 |
| Rook, AH | 1 |
| Jegasothy, BV | 1 |
| Heald, P | 1 |
| Nahass, GT | 1 |
| Ditre, C | 1 |
| Witmer, WK | 1 |
| Lazarus, GS | 1 |
| Edelson, RL | 1 |
| Tan-Lim, R | 1 |
| Friedman-Birnbaum, R | 1 |
| Schechter, Y | 1 |
| Bochner, H | 1 |
| Usuba, Y | 1 |
| Aiba, S | 1 |
| Hashimoto, K | 1 |
| Tanita, Y | 1 |
| Sakai, K | 1 |
| Neumann, RA | 1 |
| Knobler, RM | 1 |
| Metze, D | 1 |
| Jurecka, W | 1 |
| Smolle, J | 1 |
| Walton, S | 1 |
| Keczkes, K | 1 |
| Leibovici, V | 1 |
| Zeidenbaum, M | 1 |
| Goldenhersh, M | 1 |
| Seidenbaum, M | 1 |
| Sandbank, M | 1 |
| Bilet, S | 1 |
| Faucher, F | 1 |
| Crickx, B | 1 |
| Belaïch, S | 1 |
| Vissuzaine, C | 1 |
| Fine, JD | 1 |
| Appell, ML | 1 |
| Green, LK | 1 |
| Sams, WM | 1 |
| Mobacken, H | 1 |
| Al Karawi, M | 1 |
| Coode, P | 1 |
| Lennard, L | 1 |
| Harrington, CI | 1 |
| Wood, M | 1 |
| Maddocks, JL | 1 |
| Hup, JM | 1 |
| Bruinsma, RA | 1 |
| Boersma, ER | 1 |
| de Jong, MC | 1 |
| Hombal, S | 1 |
| Aberer, W | 1 |
| Wolff-Schreiner, EC | 1 |
| Stingl, G | 1 |
| Wolff, K | 2 |
| Piette-Brion, B | 1 |
| de Bast, C | 1 |
| Chamoun, E | 1 |
| de Dobbeleer, G | 1 |
| André, J | 1 |
| Huybrechts, A | 1 |
| Ledoux, M | 1 |
| Achten, G | 1 |
| Burton, JL | 3 |
| Greaves, MW | 3 |
| Marks, J | 1 |
| Dawber, RP | 1 |
| Moeschlin, S | 1 |
| van Vloten, WA | 1 |
| Roenigk, HH | 1 |
| Deodhar, S | 1 |
| Chorzelski, TP | 1 |
| Maciejowski, E | 1 |
| DeMento, FJ | 1 |
| Grover, RW | 1 |
| Beutner, EH | 1 |
| Tuffanelli, DL | 1 |
| Bean, SF | 1 |
| Lechner, K | 1 |
| Muller, SA | 1 |
| van Dijk, TJ | 1 |
| van Velde, JL | 1 |
| Ashton, H | 1 |
| Beveridge, GW | 1 |
| Stevenson, CJ | 1 |
| Schreiner, E | 1 |
| Rassner, G | 1 |
| Wenig, KH | 1 |
| Schuppli, R | 2 |
| Puissant, A | 1 |
| Chérif-Cheikh, JL | 1 |
| David, V | 1 |
| Audebert, G | 1 |
| Beurey, J | 1 |
| Weber, M | 1 |
| Vadot, J | 1 |
| Touret, D | 1 |
| Krakowski, A | 1 |
| Covo, J | 1 |
| Rozanski, Z | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open Randomized Comparative Trial of Four Different Dressings for Cutaneous Coverage in Pemphigus and Pemphigoid[NCT02365675] | 12 participants (Anticipated) | Interventional | 2015-01-31 | Recruiting | |||
| European Randomised Placebo-Controlled Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus (Pempuls Trial)[NCT00127764] | Phase 2/Phase 3 | 60 participants | Interventional | 2001-01-31 | Completed | ||
| A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Bullous Pemphigoid[NCT00431119] | Phase 2 | 70 participants | Interventional | 1997-10-31 | Completed | ||
| Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients[NCT04096222] | 42 participants (Anticipated) | Observational | 2021-06-29 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
36 reviews available for azathioprine and Pemphigus
| Article | Year |
|---|---|
Treatment of pemphigus in Australia: Aligning current practises with global recommendations.
Topics: Adrenal Cortex Hormones; Australia; Azathioprine; Humans; Immunosuppressive Agents; Pemphigus; Ritux | 2022 |
Treatment of pemphigus in Australia: Aligning current practises with global recommendations.
Topics: Adrenal Cortex Hormones; Australia; Azathioprine; Humans; Immunosuppressive Agents; Pemphigus; Ritux | 2022 |
[Bullous skin diseases].
Topics: Autoimmune Diseases; Azathioprine; Glucocorticoids; Humans; Methotrexate; Pemphigus; Rituximab; Skin | 2022 |
[Bullous skin diseases].
Topics: Autoimmune Diseases; Azathioprine; Glucocorticoids; Humans; Methotrexate; Pemphigus; Rituximab; Skin | 2022 |
[Pemphigus: current and future treatment strategies].
Topics: Adrenal Cortex Hormones; Azathioprine; Humans; Immunosuppressive Agents; Pemphigus; Rituximab | 2022 |
[Pemphigus: current and future treatment strategies].
Topics: Adrenal Cortex Hormones; Azathioprine; Humans; Immunosuppressive Agents; Pemphigus; Rituximab | 2022 |
Pemphigus.
Topics: Adrenal Cortex Hormones; Azathioprine; Desmoglein 1; Enzyme-Linked Immunosorbent Assay; Humans; Immu | 2019 |
Pemphigus.
Topics: Adrenal Cortex Hormones; Azathioprine; Desmoglein 1; Enzyme-Linked Immunosorbent Assay; Humans; Immu | 2019 |
Network meta-analysis-based comparison of first-line steroid-sparing adjuvants in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunologic Factors | 2021 |
Network meta-analysis-based comparison of first-line steroid-sparing adjuvants in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunologic Factors | 2021 |
Pemphigus herpetiformis - a case report of a rare form of pemphigus and review of the literature.
Topics: Adrenal Cortex Hormones; Aged; Autoantibodies; Azathioprine; Biomarkers; Biopsy; Dapsone; Dermatitis | 2016 |
Pemphigus herpetiformis - a case report of a rare form of pemphigus and review of the literature.
Topics: Adrenal Cortex Hormones; Aged; Autoantibodies; Azathioprine; Biomarkers; Biopsy; Dapsone; Dermatitis | 2016 |
[Therapy of pemphigus].
Topics: Azathioprine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Mycop | 2019 |
[Therapy of pemphigus].
Topics: Azathioprine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Mycop | 2019 |
Management of pemphigus disease in pregnancy.
Topics: Adrenal Cortex Hormones; Azathioprine; Female; Fetal Development; Humans; Immunoglobulins, Intraveno | 2017 |
Management of pemphigus disease in pregnancy.
Topics: Adrenal Cortex Hormones; Azathioprine; Female; Fetal Development; Humans; Immunoglobulins, Intraveno | 2017 |
Oral pemphigus vulgaris: a case report with review of the literature.
Topics: Adult; Azathioprine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Mouth Diseases; Pemp | 2008 |
Oral pemphigus vulgaris: a case report with review of the literature.
Topics: Adult; Azathioprine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Mouth Diseases; Pemp | 2008 |
Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.
Topics: Adrenal Cortex Hormones; Aged; Autoantibodies; Azathioprine; Biomarkers; Biopsy, Needle; Combined Mo | 2009 |
Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.
Topics: Adrenal Cortex Hormones; Aged; Autoantibodies; Azathioprine; Biomarkers; Biopsy, Needle; Combined Mo | 2009 |
Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes.
Topics: Adolescent; Adult; Azathioprine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infant, | 2009 |
Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes.
Topics: Adolescent; Adult; Azathioprine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infant, | 2009 |
Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Azathioprine; B-Lymphocytes; Chi | 2010 |
Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Azathioprine; B-Lymphocytes; Chi | 2010 |
Association between cancer and immunosuppressive therapy--analysis of selected studies in pemphigus and pemphigoid.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Neoplasms; Pemphigoi | 2010 |
Association between cancer and immunosuppressive therapy--analysis of selected studies in pemphigus and pemphigoid.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Neoplasms; Pemphigoi | 2010 |
A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Epidermal Growth Factor; Glucocorticoids; Humans; Immunosuppressive | 2011 |
A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Epidermal Growth Factor; Glucocorticoids; Humans; Immunosuppressive | 2011 |
Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Dapsone; Dermatologic Agents; Epidermal Growth Factor; | 2011 |
Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Dapsone; Dermatologic Agents; Epidermal Growth Factor; | 2011 |
Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).
Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Mur | 2011 |
Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).
Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Mur | 2011 |
Pemphigus: current therapy.
Topics: Animals; Antirheumatic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; | 2004 |
Pemphigus: current therapy.
Topics: Animals; Antirheumatic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; | 2004 |
Acute paronychia heralding the exacerbation of pemphigus vulgaris.
Topics: Anti-Inflammatory Agents; Azathioprine; Female; Humans; Hydrocortisone; Immunosuppressive Agents; Mi | 2004 |
Acute paronychia heralding the exacerbation of pemphigus vulgaris.
Topics: Anti-Inflammatory Agents; Azathioprine; Female; Humans; Hydrocortisone; Immunosuppressive Agents; Mi | 2004 |
Number II. Pemphigus vulgaris.
Topics: Adrenal Cortex Hormones; Azathioprine; Blister; Cadherins; Cytoskeletal Proteins; Desmoglein 1; Desm | 2005 |
Number II. Pemphigus vulgaris.
Topics: Adrenal Cortex Hormones; Azathioprine; Blister; Cadherins; Cytoskeletal Proteins; Desmoglein 1; Desm | 2005 |
Oral pemphigus vulgaris in children and adolescents: a review of the literature and a case report.
Topics: Adolescent; Anti-Inflammatory Agents; Azathioprine; Child; Complement C3; Female; Humans; Immunoglob | 2005 |
Oral pemphigus vulgaris in children and adolescents: a review of the literature and a case report.
Topics: Adolescent; Anti-Inflammatory Agents; Azathioprine; Child; Complement C3; Female; Humans; Immunoglob | 2005 |
Cutaneous reactions to rheumatological drugs.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Azathioprine; Cushing Syndrome; Cy | 1982 |
Cutaneous reactions to rheumatological drugs.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Azathioprine; Cushing Syndrome; Cy | 1982 |
Adjuvant therapy of pemphigus.
Topics: Adrenal Cortex Hormones; Antibodies; Azathioprine; Cell Count; Clinical Trials as Topic; Cyclophosph | 1984 |
Adjuvant therapy of pemphigus.
Topics: Adrenal Cortex Hormones; Antibodies; Azathioprine; Cell Count; Clinical Trials as Topic; Cyclophosph | 1984 |
The treatment of pemphigus and pemphigoid.
Topics: Aged; Azathioprine; Cosyntropin; Drug Therapy, Combination; Humans; Methylprednisolone; Pemphigoid, | 1982 |
The treatment of pemphigus and pemphigoid.
Topics: Aged; Azathioprine; Cosyntropin; Drug Therapy, Combination; Humans; Methylprednisolone; Pemphigoid, | 1982 |
Azathioprine.
Topics: Arthritis, Rheumatoid; Azathioprine; Behcet Syndrome; Bone Marrow; Colitis, Ulcerative; Crohn Diseas | 1981 |
Azathioprine.
Topics: Arthritis, Rheumatoid; Azathioprine; Behcet Syndrome; Bone Marrow; Colitis, Ulcerative; Crohn Diseas | 1981 |
Management of the immunobullous disorders. II. Pemphigus.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Pemphigus | 1995 |
Management of the immunobullous disorders. II. Pemphigus.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Pemphigus | 1995 |
The adjuvant therapy of pemphigus. An update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Azathioprine; Chemotherapy, Adjuvant; Cyclophosph | 1996 |
The adjuvant therapy of pemphigus. An update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Azathioprine; Chemotherapy, Adjuvant; Cyclophosph | 1996 |
Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Drug Co | 2000 |
Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Drug Co | 2000 |
[Indications and limits of long-term therapy with immunosuppressive (and cytostatic) agents in various chronic skin diseases].
Topics: Arthritis, Reactive; Azathioprine; Chronic Disease; Cyclophosphamide; Dermatomyositis; Humans; Immun | 1977 |
[Indications and limits of long-term therapy with immunosuppressive (and cytostatic) agents in various chronic skin diseases].
Topics: Arthritis, Reactive; Azathioprine; Chronic Disease; Cyclophosphamide; Dermatomyositis; Humans; Immun | 1977 |
[Current pharmacotherapy of pemphigus].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Antiviral Agents; Azathioprine; Cyclophosphamide; Estrogen | 1977 |
[Current pharmacotherapy of pemphigus].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Antiviral Agents; Azathioprine; Cyclophosphamide; Estrogen | 1977 |
Azathioprine in dermatology.
Topics: Azathioprine; Drug Interactions; Eczema; Humans; Leukopenia; Pemphigoid, Bullous; Pemphigus; Skin Di | 1991 |
Azathioprine in dermatology.
Topics: Azathioprine; Drug Interactions; Eczema; Humans; Leukopenia; Pemphigoid, Bullous; Pemphigus; Skin Di | 1991 |
[A fatal case of pemphigus vulgaris with interstitial pneumonia occurring during gold therapy].
Topics: Azathioprine; Drug Therapy, Combination; Female; Gold Sodium Thiomalate; Humans; Middle Aged; Pemphi | 1989 |
[A fatal case of pemphigus vulgaris with interstitial pneumonia occurring during gold therapy].
Topics: Azathioprine; Drug Therapy, Combination; Female; Gold Sodium Thiomalate; Humans; Middle Aged; Pemphi | 1989 |
Disseminated superficial porokeratosis and immunosuppression.
Topics: Aged; Azathioprine; Drug Eruptions; Humans; Immunosuppression Therapy; Keratosis; Male; Pemphigus; P | 1988 |
Disseminated superficial porokeratosis and immunosuppression.
Topics: Aged; Azathioprine; Drug Eruptions; Humans; Immunosuppression Therapy; Keratosis; Male; Pemphigus; P | 1988 |
Chronic nonhereditary blistering disease in children.
Topics: Anti-Infective Agents; Azathioprine; Blister; Child; Child, Preschool; Chronic Disease; Corticostero | 1974 |
Chronic nonhereditary blistering disease in children.
Topics: Anti-Infective Agents; Azathioprine; Blister; Child; Child, Preschool; Chronic Disease; Corticostero | 1974 |
Acquired inhibitors in nonhemophilic patients.
Topics: Arthritis, Rheumatoid; Azathioprine; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Pro | 1974 |
Acquired inhibitors in nonhemophilic patients.
Topics: Arthritis, Rheumatoid; Azathioprine; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Pro | 1974 |
Immunosuppressants in the treatment of pemphigus.
Topics: Adult; Aged; Azathioprine; Drug Resistance, Microbial; Female; Humans; Infections; Male; Methotrexat | 1970 |
Immunosuppressants in the treatment of pemphigus.
Topics: Adult; Aged; Azathioprine; Drug Resistance, Microbial; Female; Humans; Infections; Male; Methotrexat | 1970 |
Therapeutics. XI. Immunosuppressive drugs.
Topics: Adrenal Cortex Hormones; Animals; Antibody Formation; Autoimmune Diseases; Azathioprine; Cyclophosph | 1970 |
Therapeutics. XI. Immunosuppressive drugs.
Topics: Adrenal Cortex Hormones; Animals; Antibody Formation; Autoimmune Diseases; Azathioprine; Cyclophosph | 1970 |
15 trials available for azathioprine and Pemphigus
| Article | Year |
|---|---|
Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial.
Topics: Adult; Aged; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Hu | 2015 |
Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial.
Topics: Adult; Aged; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Hu | 2015 |
Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris.
Topics: Administration, Oral; Adult; Azathioprine; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Therapy, C | 2014 |
Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris.
Topics: Administration, Oral; Adult; Azathioprine; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Therapy, C | 2014 |
[Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; Autoantigens; Azathioprine; Cyclophosphamide; Desmog | 2009 |
[Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; Autoantigens; Azathioprine; Cyclophosphamide; Desmog | 2009 |
Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris.
Topics: Adult; Azathioprine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combinatio | 2013 |
Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris.
Topics: Adult; Azathioprine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combinatio | 2013 |
New approaches to the treatment of pemphigus.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Azathioprine; Cholinesterase Inhibitors; Dr | 2004 |
New approaches to the treatment of pemphigus.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Azathioprine; Cholinesterase Inhibitors; Dr | 2004 |
Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Cyclop | 2005 |
Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Cyclop | 2005 |
Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Chemotherapy, Adjuvant; D | 2006 |
Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Chemotherapy, Adjuvant; D | 2006 |
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
Topics: Administration, Oral; Anti-Inflammatory Agents; Azathioprine; Disease-Free Survival; Drug Therapy, C | 2006 |
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
Topics: Administration, Oral; Anti-Inflammatory Agents; Azathioprine; Disease-Free Survival; Drug Therapy, C | 2006 |
Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
Topics: Adult; Azathioprine; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; | 2007 |
Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
Topics: Adult; Azathioprine; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; | 2007 |
Adjuvant therapy of pemphigus.
Topics: Adrenal Cortex Hormones; Antibodies; Azathioprine; Cell Count; Clinical Trials as Topic; Cyclophosph | 1984 |
Adjuvant therapy of pemphigus.
Topics: Adrenal Cortex Hormones; Antibodies; Azathioprine; Cell Count; Clinical Trials as Topic; Cyclophosph | 1984 |
Steroid-pulse therapy in pemphigus vulgaris long term follow-up.
Topics: Administration, Oral; Adolescent; Adult; Autoantibodies; Azathioprine; Cyclophosphamide; Drug Therap | 1995 |
Steroid-pulse therapy in pemphigus vulgaris long term follow-up.
Topics: Administration, Oral; Adolescent; Adult; Autoantibodies; Azathioprine; Cyclophosphamide; Drug Therap | 1995 |
Treatment of pemphigus: a local experience.
Topics: Anti-Inflammatory Agents; Azathioprine; Betamethasone; Chi-Square Distribution; Cyclophosphamide; Dr | 1998 |
Treatment of pemphigus: a local experience.
Topics: Anti-Inflammatory Agents; Azathioprine; Betamethasone; Chi-Square Distribution; Cyclophosphamide; Dr | 1998 |
Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients.
Topics: Adult; Anti-Bacterial Agents; Azathioprine; Chemotherapy, Adjuvant; Drug Therapy, Combination; Femal | 1999 |
Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients.
Topics: Adult; Anti-Bacterial Agents; Azathioprine; Chemotherapy, Adjuvant; Drug Therapy, Combination; Femal | 1999 |
Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antibodies; Azathioprine; Cyclophosphamide; | 1990 |
Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antibodies; Azathioprine; Cyclophosphamide; | 1990 |
[Treatment of pemphigus].
Topics: Adult; Antimetabolites, Antineoplastic; Azathioprine; Clinical Trials as Topic; Drug Evaluation; Dru | 1974 |
[Treatment of pemphigus].
Topics: Adult; Antimetabolites, Antineoplastic; Azathioprine; Clinical Trials as Topic; Drug Evaluation; Dru | 1974 |
174 other studies available for azathioprine and Pemphigus
| Article | Year |
|---|---|
Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study.
Topics: Azathioprine; China; Humans; Pemphigus; Prospective Studies; Pyrophosphatases | 2022 |
Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study.
Topics: Azathioprine; China; Humans; Pemphigus; Prospective Studies; Pyrophosphatases | 2022 |
A case report of the beneficial effect of oclacitinib in a dog with pemphigus vulgaris.
Topics: Animals; Azathioprine; Dog Diseases; Dogs; Immunosuppressive Agents; Pemphigus; Pyrimidines; Sulfona | 2022 |
A case report of the beneficial effect of oclacitinib in a dog with pemphigus vulgaris.
Topics: Animals; Azathioprine; Dog Diseases; Dogs; Immunosuppressive Agents; Pemphigus; Pyrimidines; Sulfona | 2022 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Rituximab and risk of infections in patients with pemphigus: answers from a global population-based cohort study.
Topics: Azathioprine; Cohort Studies; Humans; Mycophenolic Acid; Pemphigus; Rituximab; Treatment Outcome | 2023 |
Rituximab and risk of infections in patients with pemphigus: answers from a global population-based cohort study.
Topics: Azathioprine; Cohort Studies; Humans; Mycophenolic Acid; Pemphigus; Rituximab; Treatment Outcome | 2023 |
Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study.
Topics: Azathioprine; Cohort Studies; COVID-19; Cytomegalovirus Infections; Humans; Immunosuppressive Agents | 2023 |
Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study.
Topics: Azathioprine; Cohort Studies; COVID-19; Cytomegalovirus Infections; Humans; Immunosuppressive Agents | 2023 |
Paraneoplastic pemphigus and Castleman's disease: a case report and a revision of the literature.
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Castleman Disease; Child; Female; Humans; Pemphig | 2023 |
Paraneoplastic pemphigus and Castleman's disease: a case report and a revision of the literature.
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Castleman Disease; Child; Female; Humans; Pemphig | 2023 |
Rescue treatment with intravenous immunoglobulin and amniotic membrane dressing in refractory paediatric pemphigus vulgaris with sepsis.
Topics: Azathioprine; Biological Dressings; Child; Dapsone; Humans; Immunoglobulins, Intravenous; Pemphigus; | 2023 |
Rescue treatment with intravenous immunoglobulin and amniotic membrane dressing in refractory paediatric pemphigus vulgaris with sepsis.
Topics: Azathioprine; Biological Dressings; Child; Dapsone; Humans; Immunoglobulins, Intravenous; Pemphigus; | 2023 |
The use of oclacitinib compared to azathioprine in the management of canine pemphigus foliaceus: A retrospective analysis.
Topics: Animals; Azathioprine; Dog Diseases; Dogs; Glucocorticoids; Humans; Pemphigus; Retrospective Studies | 2023 |
The use of oclacitinib compared to azathioprine in the management of canine pemphigus foliaceus: A retrospective analysis.
Topics: Animals; Azathioprine; Dog Diseases; Dogs; Glucocorticoids; Humans; Pemphigus; Retrospective Studies | 2023 |
A case of cytomegalovirus-induced haemorrhagic cystitis during treatment of pemphigus foliaceus with corticosteroids and azathioprine.
Topics: Adrenal Cortex Hormones; Azathioprine; Cytomegalovirus; Humans; Immunosuppressive Agents; Pemphigus | 2023 |
A case of cytomegalovirus-induced haemorrhagic cystitis during treatment of pemphigus foliaceus with corticosteroids and azathioprine.
Topics: Adrenal Cortex Hormones; Azathioprine; Cytomegalovirus; Humans; Immunosuppressive Agents; Pemphigus | 2023 |
Pemphigus Vegetans of Hallopeau: A Case Report.
Topics: Azathioprine; Blister; Eosinophilia; Humans; Male; Middle Aged; Pemphigus; Prednisolone; Skin; Stero | 2023 |
Pemphigus Vegetans of Hallopeau: A Case Report.
Topics: Azathioprine; Blister; Eosinophilia; Humans; Male; Middle Aged; Pemphigus; Prednisolone; Skin; Stero | 2023 |
Methylprednisolone pulse therapy plus adjuvant therapy for pemphigus vulgaris: an analysis of 10 years' experience on 312 patients.
Topics: Administration, Oral; Adult; Azathioprine; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; | 2019 |
Methylprednisolone pulse therapy plus adjuvant therapy for pemphigus vulgaris: an analysis of 10 years' experience on 312 patients.
Topics: Administration, Oral; Adult; Azathioprine; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; | 2019 |
Results of the guideline-based treatment for pemphigus: a single-centre experience with 84 cases.
Topics: Aged; Azathioprine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Pemphigus; Predniso | 2020 |
Results of the guideline-based treatment for pemphigus: a single-centre experience with 84 cases.
Topics: Aged; Azathioprine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Pemphigus; Predniso | 2020 |
Neutropenic fever with diffuse alopecia in a patient with pemphigus foliaceus during azathioprine treatment.
Topics: Alopecia Areata; Azathioprine; Humans; Immunosuppressive Agents; Pemphigus | 2020 |
Neutropenic fever with diffuse alopecia in a patient with pemphigus foliaceus during azathioprine treatment.
Topics: Alopecia Areata; Azathioprine; Humans; Immunosuppressive Agents; Pemphigus | 2020 |
Pemphigus Vulgaris: A Retrospective Cohort Study of Clinical Features, Treatments, and Outcomes.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Female; Humans; Pemphigus; Retrospective Studies; Skin | 2020 |
Pemphigus Vulgaris: A Retrospective Cohort Study of Clinical Features, Treatments, and Outcomes.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Female; Humans; Pemphigus; Retrospective Studies; Skin | 2020 |
Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus.
Topics: Azathioprine; B-Lymphocytes, Regulatory; Drug Therapy, Combination; Glucocorticoids; Humans; Immunos | 2021 |
Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus.
Topics: Azathioprine; B-Lymphocytes, Regulatory; Drug Therapy, Combination; Glucocorticoids; Humans; Immunos | 2021 |
Epidemiology and Factors Associated with Remission of Pemphigus Vulgaris and Foliaceus in Singapore.
Topics: Autoantibodies; Azathioprine; Humans; Pemphigus; Prednisolone; Retrospective Studies; Singapore | 2020 |
Epidemiology and Factors Associated with Remission of Pemphigus Vulgaris and Foliaceus in Singapore.
Topics: Autoantibodies; Azathioprine; Humans; Pemphigus; Prednisolone; Retrospective Studies; Singapore | 2020 |
Complete remission of refractory pemphigus vulgaris in a Chinese patient with mutated NUDT15 by combination of minimal doses of azathioprine and prednisone.
Topics: Asian People; Azathioprine; China; Humans; Male; Pemphigus; Prednisone | 2020 |
Complete remission of refractory pemphigus vulgaris in a Chinese patient with mutated NUDT15 by combination of minimal doses of azathioprine and prednisone.
Topics: Asian People; Azathioprine; China; Humans; Male; Pemphigus; Prednisone | 2020 |
Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Midd | 2021 |
Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Midd | 2021 |
Combination therapy with azathioprine, cyclosporine and ketoconazole in a dog with concurrent pemphigus foliaceus and hyperadrenocorticism - Case report.
Topics: Adrenocortical Hyperfunction; Animals; Azathioprine; Cyclosporine; Dog Diseases; Dogs; Drug Combinat | 2020 |
Combination therapy with azathioprine, cyclosporine and ketoconazole in a dog with concurrent pemphigus foliaceus and hyperadrenocorticism - Case report.
Topics: Adrenocortical Hyperfunction; Animals; Azathioprine; Cyclosporine; Dog Diseases; Dogs; Drug Combinat | 2020 |
Identification of factors associated with treatment refractoriness of oral lesions in pemphigus vulgaris.
Topics: Adult; Antibodies; Azathioprine; Cyclophosphamide; Dermatologic Agents; Desmoglein 1; Desmoglein 3; | 2017 |
Identification of factors associated with treatment refractoriness of oral lesions in pemphigus vulgaris.
Topics: Adult; Antibodies; Azathioprine; Cyclophosphamide; Dermatologic Agents; Desmoglein 1; Desmoglein 3; | 2017 |
NUDT15 polymorphism and severe azathioprine-induced myelosuppression in a Chinese man with pemphigus vulgaris.
Topics: Azathioprine; Bone Marrow Diseases; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelopoiesi | 2018 |
NUDT15 polymorphism and severe azathioprine-induced myelosuppression in a Chinese man with pemphigus vulgaris.
Topics: Azathioprine; Bone Marrow Diseases; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelopoiesi | 2018 |
Azathioprine monotherapy in autoimmune blistering diseases: A feasible option for mild to moderate cases.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Feasibility Studies; Female; Humans; Immunosuppressive | 2018 |
Azathioprine monotherapy in autoimmune blistering diseases: A feasible option for mild to moderate cases.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Feasibility Studies; Female; Humans; Immunosuppressive | 2018 |
Pemphigus herpetiformis with autoantibodies to desmocollins 1, 2 and 3.
Topics: Aged; Autoantibodies; Azathioprine; Desmocollins; Glucocorticoids; Humans; Immunosuppressive Agents; | 2018 |
Pemphigus herpetiformis with autoantibodies to desmocollins 1, 2 and 3.
Topics: Aged; Autoantibodies; Azathioprine; Desmocollins; Glucocorticoids; Humans; Immunosuppressive Agents; | 2018 |
Psoriasis vulgaris in a patient with pemphigus vulgaris on corticosteroid therapy.
Topics: Azathioprine; Biopsy; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; | 2018 |
Psoriasis vulgaris in a patient with pemphigus vulgaris on corticosteroid therapy.
Topics: Azathioprine; Biopsy; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; | 2018 |
Azathioprine-induced myelosuppression in two pemphigus vulgaris patients with homozygous polymorphism of NUDT15.
Topics: Adult; Azathioprine; Blood Cell Count; Coinfection; Drug Therapy, Combination; Female; Homozygote; H | 2019 |
Azathioprine-induced myelosuppression in two pemphigus vulgaris patients with homozygous polymorphism of NUDT15.
Topics: Adult; Azathioprine; Blood Cell Count; Coinfection; Drug Therapy, Combination; Female; Homozygote; H | 2019 |
Two cases of pemphigus vulgaris in remission showing high titer of anti-desmoglein 3 antibodies.
Topics: Autoantibodies; Azathioprine; Desmoglein 3; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoi | 2019 |
Two cases of pemphigus vulgaris in remission showing high titer of anti-desmoglein 3 antibodies.
Topics: Autoantibodies; Azathioprine; Desmoglein 3; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoi | 2019 |
Painful ulceration of the vulva.
Topics: Adult; Azathioprine; Female; Gingival Diseases; Glucocorticoids; Humans; Immunologic Factors; Pemphi | 2019 |
Painful ulceration of the vulva.
Topics: Adult; Azathioprine; Female; Gingival Diseases; Glucocorticoids; Humans; Immunologic Factors; Pemphi | 2019 |
Emergence of multidrug-resistant Candida auris in Taiwan.
Topics: Azathioprine; Candida; Candidiasis; Dermatomycoses; Diabetes Complications; Drug Resistance, Multipl | 2019 |
Emergence of multidrug-resistant Candida auris in Taiwan.
Topics: Azathioprine; Candida; Candidiasis; Dermatomycoses; Diabetes Complications; Drug Resistance, Multipl | 2019 |
Maintenance therapy with azathioprine prolonged duration of remission for pemphigus patients who received rituximab as first-line or add-on therapy.
Topics: Adult; Aged; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Logi | 2020 |
Maintenance therapy with azathioprine prolonged duration of remission for pemphigus patients who received rituximab as first-line or add-on therapy.
Topics: Adult; Aged; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Logi | 2020 |
Recurrent Asymptomatic Sigmoid Diverticular Perforation in a Patient with Pemphigus Vulgaris on Immunosuppressive Therapy: A Case Report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Diverticulum, Colon; Humans; Immunosuppressiv | 2019 |
Recurrent Asymptomatic Sigmoid Diverticular Perforation in a Patient with Pemphigus Vulgaris on Immunosuppressive Therapy: A Case Report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Diverticulum, Colon; Humans; Immunosuppressiv | 2019 |
Strongyloidiasis complicating immunosuppression for pemphigus vulgaris.
Topics: Adult; Animals; Azathioprine; Dermatologic Agents; Female; Humans; Immunosuppressive Agents; Opportu | 2013 |
Strongyloidiasis complicating immunosuppression for pemphigus vulgaris.
Topics: Adult; Animals; Azathioprine; Dermatologic Agents; Female; Humans; Immunosuppressive Agents; Opportu | 2013 |
Opportunistic infections in patients with pemphigus.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Cytomegalovirus | 2014 |
Opportunistic infections in patients with pemphigus.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Cytomegalovirus | 2014 |
A blistering response: concurrent psoriasis and pemphigus foliaceus.
Topics: Adrenal Cortex Hormones; Azathioprine; Female; Humans; Immunosuppressive Agents; Middle Aged; Pemphi | 2015 |
A blistering response: concurrent psoriasis and pemphigus foliaceus.
Topics: Adrenal Cortex Hormones; Azathioprine; Female; Humans; Immunosuppressive Agents; Middle Aged; Pemphi | 2015 |
Treatment outcomes in a cohort of patients with mucosal-predominant pemphigus vulgaris.
Topics: Adult; Aged; Azathioprine; Cohort Studies; Female; Humans; Immunosuppressive Agents; Male; Middle Ag | 2015 |
Treatment outcomes in a cohort of patients with mucosal-predominant pemphigus vulgaris.
Topics: Adult; Aged; Azathioprine; Cohort Studies; Female; Humans; Immunosuppressive Agents; Male; Middle Ag | 2015 |
Unusual Histological Evidence of Dysplasia in a Case of Oral Pemphigus Vulgaris: A Potential Diagnostic Challenge.
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combination; Humans; Immunosuppressive A | 2016 |
Unusual Histological Evidence of Dysplasia in a Case of Oral Pemphigus Vulgaris: A Potential Diagnostic Challenge.
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combination; Humans; Immunosuppressive A | 2016 |
Low-dose rituximab and concurrent adjuvant therapy for pemphigus: Protocol and single-centre long-term review of nine patients.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; B-Lymphocytes; Drug Therapy, Combination; Femal | 2018 |
Low-dose rituximab and concurrent adjuvant therapy for pemphigus: Protocol and single-centre long-term review of nine patients.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; B-Lymphocytes; Drug Therapy, Combination; Femal | 2018 |
Contact pemphigus: a side-effect of imiquimod therapy.
Topics: Administration, Topical; Aminoquinolines; Azathioprine; Biopsy, Needle; Dose-Response Relationship, | 2008 |
Contact pemphigus: a side-effect of imiquimod therapy.
Topics: Administration, Topical; Aminoquinolines; Azathioprine; Biopsy, Needle; Dose-Response Relationship, | 2008 |
Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies.
Topics: Animals; Azathioprine; Body Weight; Cyclophosphamide; Cyclosporine; Desmoglein 3; Dexamethasone; Dis | 2009 |
Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies.
Topics: Animals; Azathioprine; Body Weight; Cyclophosphamide; Cyclosporine; Desmoglein 3; Dexamethasone; Dis | 2009 |
Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
Topics: Adult; Azathioprine; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Drug Therapy, Co | 2008 |
Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
Topics: Adult; Azathioprine; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Drug Therapy, Co | 2008 |
Recalcitrant pemphigus foliaceus with Kaposi's varicelliform eruption: report of a fatal case.
Topics: Aged, 80 and over; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Fatal Outcome; | 2008 |
Recalcitrant pemphigus foliaceus with Kaposi's varicelliform eruption: report of a fatal case.
Topics: Aged, 80 and over; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Fatal Outcome; | 2008 |
[Epidemiology of pemphigus in the Hospital Universitario Virgen Macarena, Seville, Spain, 2005-2006].
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cushing Syndrome; Drug Therapy, Combination; Fem | 2009 |
[Epidemiology of pemphigus in the Hospital Universitario Virgen Macarena, Seville, Spain, 2005-2006].
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cushing Syndrome; Drug Therapy, Combination; Fem | 2009 |
Thioguanine nucleotides and thiopurine methyltransferase in immunobullous diseases: optimal levels as adjunctive tools for azathioprine monitoring.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Dose-Response Relationship, Drug; Drug Administration | 2009 |
Thioguanine nucleotides and thiopurine methyltransferase in immunobullous diseases: optimal levels as adjunctive tools for azathioprine monitoring.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Dose-Response Relationship, Drug; Drug Administration | 2009 |
Aplasia cutis congenita associated with azathioprine.
Topics: Adult; Antirheumatic Agents; Azathioprine; Ectodermal Dysplasia; Fatal Outcome; Female; Humans; Infa | 2009 |
Aplasia cutis congenita associated with azathioprine.
Topics: Adult; Antirheumatic Agents; Azathioprine; Ectodermal Dysplasia; Fatal Outcome; Female; Humans; Infa | 2009 |
Pemphigus vulgaris--still a difficult disease to treat.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Azathi | 2010 |
Pemphigus vulgaris--still a difficult disease to treat.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Azathi | 2010 |
Strongyloides stercoralis hyperinfection in a diabetic patient: case report.
Topics: Aged; Animals; Azathioprine; Diabetes Mellitus; Humans; Immunosuppressive Agents; Male; Pemphigus; P | 2010 |
Strongyloides stercoralis hyperinfection in a diabetic patient: case report.
Topics: Aged; Animals; Azathioprine; Diabetes Mellitus; Humans; Immunosuppressive Agents; Male; Pemphigus; P | 2010 |
High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Dose-Response Relationshi | 2011 |
High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Dose-Response Relationshi | 2011 |
Recalcitrant pemphigus vulgaris responding to systemic tacrolimus.
Topics: Adrenal Cortex Hormones; Aged; Autoantibodies; Azathioprine; Cyclophosphamide; Dapsone; Dermatologic | 2010 |
Recalcitrant pemphigus vulgaris responding to systemic tacrolimus.
Topics: Adrenal Cortex Hormones; Aged; Autoantibodies; Azathioprine; Cyclophosphamide; Dapsone; Dermatologic | 2010 |
Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Autoantibodies; Azathioprine; Cyclophosphamid | 2011 |
Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Autoantibodies; Azathioprine; Cyclophosphamid | 2011 |
Pemphigus vulgaris in three adolescents: the course of the disease.
Topics: Adolescent; Azathioprine; Dapsone; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids | 2011 |
Pemphigus vulgaris in three adolescents: the course of the disease.
Topics: Adolescent; Azathioprine; Dapsone; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids | 2011 |
Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Azathioprine; Desmogleins; Dexa | 2012 |
Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Azathioprine; Desmogleins; Dexa | 2012 |
Case records of the Massachusetts General Hospital. Case 28-2011. A 74-year-old man with pemphigus vulgaris and lung nodules.
Topics: Aged; Azathioprine; Cryptococcosis; Diagnosis, Differential; Glucocorticoids; Humans; Immunocompromi | 2011 |
Case records of the Massachusetts General Hospital. Case 28-2011. A 74-year-old man with pemphigus vulgaris and lung nodules.
Topics: Aged; Azathioprine; Cryptococcosis; Diagnosis, Differential; Glucocorticoids; Humans; Immunocompromi | 2011 |
Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived | 2011 |
Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived | 2011 |
The influence of systemic therapy on the serum levels of IL-6 and IL-8 in pemphigus vulgaris.
Topics: Azathioprine; Enzyme-Linked Immunosorbent Assay; Humans; Interleukin-6; Interleukin-8; Pemphigus; Pr | 2013 |
The influence of systemic therapy on the serum levels of IL-6 and IL-8 in pemphigus vulgaris.
Topics: Azathioprine; Enzyme-Linked Immunosorbent Assay; Humans; Interleukin-6; Interleukin-8; Pemphigus; Pr | 2013 |
[A case of disseminated cryptococcosis complicating treatment of pemphigus vulgaris with prednisone and azathioprime].
Topics: Aged; Azathioprine; Cryptococcosis; Fatal Outcome; Female; Glucocorticoids; Humans; Immunosuppressiv | 2011 |
[A case of disseminated cryptococcosis complicating treatment of pemphigus vulgaris with prednisone and azathioprime].
Topics: Aged; Azathioprine; Cryptococcosis; Fatal Outcome; Female; Glucocorticoids; Humans; Immunosuppressiv | 2011 |
Epidemiology of pemphigus in the western region of Turkey: retrospective analysis of 87 patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Candidiasis, Oral; Female; G | 2012 |
Epidemiology of pemphigus in the western region of Turkey: retrospective analysis of 87 patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Candidiasis, Oral; Female; G | 2012 |
Pemphigus vulgaris--a report of three cases.
Topics: Absorptiometry, Photon; Adult; Antimetabolites; Azathioprine; Diagnosis, Differential; Endoscopy; Fe | 2012 |
Pemphigus vulgaris--a report of three cases.
Topics: Absorptiometry, Photon; Adult; Antimetabolites; Azathioprine; Diagnosis, Differential; Endoscopy; Fe | 2012 |
Varicella-zoster virus (VZV) and alpha 1 antitrypsin: a fatal outcome in a patient affected by endemic pemphigus foliaceus.
Topics: Acyclovir; Adult; alpha 1-Antitrypsin; Antiviral Agents; Azathioprine; Chickenpox; Endemic Diseases; | 2012 |
Varicella-zoster virus (VZV) and alpha 1 antitrypsin: a fatal outcome in a patient affected by endemic pemphigus foliaceus.
Topics: Acyclovir; Adult; alpha 1-Antitrypsin; Antiviral Agents; Azathioprine; Chickenpox; Endemic Diseases; | 2012 |
Study of oral, ear, nose and throat involvement in pemphigus vulgaris by endoscopic examination.
Topics: Azathioprine; Drug Therapy, Combination; Ear Diseases; Endoscopy; Glucocorticoids; Humans; Immunosup | 2012 |
Study of oral, ear, nose and throat involvement in pemphigus vulgaris by endoscopic examination.
Topics: Azathioprine; Drug Therapy, Combination; Ear Diseases; Endoscopy; Glucocorticoids; Humans; Immunosup | 2012 |
Verrucous plaques in a pemphigus vulgaris patient on immunosuppressive therapy.
Topics: Anti-Inflammatory Agents; Azathioprine; Cryotherapy; Humans; Immunosuppression Therapy; Immunosuppre | 2012 |
Verrucous plaques in a pemphigus vulgaris patient on immunosuppressive therapy.
Topics: Anti-Inflammatory Agents; Azathioprine; Cryotherapy; Humans; Immunosuppression Therapy; Immunosuppre | 2012 |
A patient with immunological features of paraneoplastic pemphigus in the absence of a detectable malignancy.
Topics: Aged; Autoantibodies; Autoantigens; Azathioprine; Cytoskeletal Proteins; Desmoplakins; Disease Progr | 2002 |
A patient with immunological features of paraneoplastic pemphigus in the absence of a detectable malignancy.
Topics: Aged; Autoantibodies; Autoantigens; Azathioprine; Cytoskeletal Proteins; Desmoplakins; Disease Progr | 2002 |
[Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)].
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Drug Therapy, Combination; Female; Glucocorticoids; Hu | 2003 |
[Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)].
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Drug Therapy, Combination; Female; Glucocorticoids; Hu | 2003 |
The prognosis of pemphigus patients will be significantly improved in the future.
Topics: Azathioprine; Blood Component Removal; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosup | 2003 |
The prognosis of pemphigus patients will be significantly improved in the future.
Topics: Azathioprine; Blood Component Removal; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosup | 2003 |
Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris.
Topics: Azathioprine; Biopsy; Drug Administration Schedule; Expert Testimony; Fluorescent Antibody Technique | 2003 |
Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris.
Topics: Azathioprine; Biopsy; Drug Administration Schedule; Expert Testimony; Fluorescent Antibody Technique | 2003 |
Pemphigus in Korea: clinical manifestations and treatment protocol.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Azathioprine; Drug Ad | 2003 |
Pemphigus in Korea: clinical manifestations and treatment protocol.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Azathioprine; Drug Ad | 2003 |
Control of childhood pemphigus erythematosus with steroids and azathioprine.
Topics: Azathioprine; Child; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Humans; Male; Pe | 2004 |
Control of childhood pemphigus erythematosus with steroids and azathioprine.
Topics: Azathioprine; Child; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Humans; Male; Pe | 2004 |
Pemphigus vulgaris with nail involvement presenting with vegetating and verrucous lesions.
Topics: Aged; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Diabetes Mellitus, Type 1; Disease Progre | 2003 |
Pemphigus vulgaris with nail involvement presenting with vegetating and verrucous lesions.
Topics: Aged; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Diabetes Mellitus, Type 1; Disease Progre | 2003 |
A novel therapeutic option in pemphigus vulgaris: humanized monoclonal anti-CD25 antibody.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Daclizumab; Drug Therapy, C | 2004 |
A novel therapeutic option in pemphigus vulgaris: humanized monoclonal anti-CD25 antibody.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Daclizumab; Drug Therapy, C | 2004 |
Prolonged remission after immunosuppressive therapy in six dogs with pemphigus foliaceus.
Topics: Animals; Azathioprine; Diagnosis, Differential; Dog Diseases; Dogs; Drug Therapy, Combination; Femal | 2004 |
Prolonged remission after immunosuppressive therapy in six dogs with pemphigus foliaceus.
Topics: Animals; Azathioprine; Diagnosis, Differential; Dog Diseases; Dogs; Drug Therapy, Combination; Femal | 2004 |
Pemphigus vulgaris with involvement of the cervix treated using thalidomide therapy.
Topics: Azathioprine; Diagnosis, Differential; Drug Administration Schedule; Drug Therapy, Combination; Fema | 2004 |
Pemphigus vulgaris with involvement of the cervix treated using thalidomide therapy.
Topics: Azathioprine; Diagnosis, Differential; Drug Administration Schedule; Drug Therapy, Combination; Fema | 2004 |
A case of Sweet's syndrome and pemphigus vulgaris.
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Fe | 2004 |
A case of Sweet's syndrome and pemphigus vulgaris.
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Fe | 2004 |
Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities.
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antig | 2004 |
Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities.
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antig | 2004 |
Pemphigus: analysis of 1209 cases.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age of Onset; Aged; Aged, 80 and over; Azathioprine; Chi | 2005 |
Pemphigus: analysis of 1209 cases.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age of Onset; Aged; Aged, 80 and over; Azathioprine; Chi | 2005 |
Development of pemphigus vulgaris in a patient with vitiligo and Hashimoto's thyroiditis.
Topics: Adult; Autoantibodies; Azathioprine; Female; Humans; Iodide Peroxidase; Pemphigus; Polyendocrinopath | 2005 |
Development of pemphigus vulgaris in a patient with vitiligo and Hashimoto's thyroiditis.
Topics: Adult; Autoantibodies; Azathioprine; Female; Humans; Iodide Peroxidase; Pemphigus; Polyendocrinopath | 2005 |
Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amenorrhea; Azathioprine; Betamethasone; Blood Pressure; | 2005 |
Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amenorrhea; Azathioprine; Betamethasone; Blood Pressure; | 2005 |
[Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulins].
Topics: Adolescent; Azathioprine; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocort | 2005 |
[Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulins].
Topics: Adolescent; Azathioprine; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocort | 2005 |
[Treatment of pemphigus vulgaris with high-dose intravenous immunoglobulins in a patient with steroid-induced osteonecrosis of the femoral head].
Topics: Adult; Azathioprine; Dose-Response Relationship, Drug; Drug Administration Schedule; Femur Head Necr | 2004 |
[Treatment of pemphigus vulgaris with high-dose intravenous immunoglobulins in a patient with steroid-induced osteonecrosis of the femoral head].
Topics: Adult; Azathioprine; Dose-Response Relationship, Drug; Drug Administration Schedule; Femur Head Necr | 2004 |
[Desmoglein 1-negative, desmoglein 3-positive pemphigus herpetiformis with involvement of oral mucous membranes].
Topics: Azathioprine; Desmoglein 1; Desmoglein 3; Female; Humans; Middle Aged; Mouth Diseases; Mouth Mucosa; | 2005 |
[Desmoglein 1-negative, desmoglein 3-positive pemphigus herpetiformis with involvement of oral mucous membranes].
Topics: Azathioprine; Desmoglein 1; Desmoglein 3; Female; Humans; Middle Aged; Mouth Diseases; Mouth Mucosa; | 2005 |
Epidemiology of pemphigus in south-western Iran: a 10-year retrospective study (1991-2000).
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anti-Infective Agents; Azathioprine; C | 2006 |
Epidemiology of pemphigus in south-western Iran: a 10-year retrospective study (1991-2000).
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anti-Infective Agents; Azathioprine; C | 2006 |
Transition from pemphigus foliaceus to pemphigus vulgaris: case report with literature review.
Topics: Adult; Aged; Autoantibodies; Autoantigens; Azathioprine; Blotting, Western; Cell Membrane; Disease P | 2006 |
Transition from pemphigus foliaceus to pemphigus vulgaris: case report with literature review.
Topics: Adult; Aged; Autoantibodies; Autoantigens; Azathioprine; Blotting, Western; Cell Membrane; Disease P | 2006 |
Involvement of the esophagus in a patient with pemphigus vulgaris who was on immunosuppressive therapy.
Topics: Adult; Azathioprine; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy, Gastroin | 2006 |
Involvement of the esophagus in a patient with pemphigus vulgaris who was on immunosuppressive therapy.
Topics: Adult; Azathioprine; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy, Gastroin | 2006 |
A simple and effective approach to pemphigus.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Pemphigus; Prednisolone | 2007 |
A simple and effective approach to pemphigus.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Pemphigus; Prednisolone | 2007 |
Think globally, act locally: expert opinions from Asia on the diagnosis and treatment of pemphigus vulgaris.
Topics: Adrenal Cortex Hormones; Asia; Azathioprine; Consensus; Fluorescent Antibody Technique, Direct; Huma | 2007 |
Think globally, act locally: expert opinions from Asia on the diagnosis and treatment of pemphigus vulgaris.
Topics: Adrenal Cortex Hormones; Asia; Azathioprine; Consensus; Fluorescent Antibody Technique, Direct; Huma | 2007 |
[Laryngeal pemphigus].
Topics: Adrenal Cortex Hormones; Azathioprine; Deglutition Disorders; Drug Therapy, Combination; Female; Flu | 2006 |
[Laryngeal pemphigus].
Topics: Adrenal Cortex Hormones; Azathioprine; Deglutition Disorders; Drug Therapy, Combination; Female; Flu | 2006 |
Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Drug Therapy, Combinat | 2007 |
Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Drug Therapy, Combinat | 2007 |
Complete remission of drug-resistant Pemphigus vegetans treated by extracorporeal photopheresis.
Topics: Azathioprine; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Humans; I | 2007 |
Complete remission of drug-resistant Pemphigus vegetans treated by extracorporeal photopheresis.
Topics: Azathioprine; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Humans; I | 2007 |
An alternate-day corticosteroid regimen for pemphigus vulgaris. A 13-year prospective study.
Topics: Administration, Oral; Adult; Aged; Azathioprine; Chi-Square Distribution; Drug Administration Schedu | 2007 |
An alternate-day corticosteroid regimen for pemphigus vulgaris. A 13-year prospective study.
Topics: Administration, Oral; Adult; Aged; Azathioprine; Chi-Square Distribution; Drug Administration Schedu | 2007 |
Outcome of pemphigus vulgaris.
Topics: Adult; Azathioprine; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combinatio | 2008 |
Outcome of pemphigus vulgaris.
Topics: Adult; Azathioprine; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combinatio | 2008 |
Treatment failure with rituximab in a patient with pemphigus vulgaris.
Topics: Aged; Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathio | 2008 |
Treatment failure with rituximab in a patient with pemphigus vulgaris.
Topics: Aged; Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathio | 2008 |
Impact of smoking on pemphigus.
Topics: Adult; Azathioprine; Case-Control Studies; Female; Humans; Immunosuppressive Agents; Iran; Male; Mid | 2008 |
Impact of smoking on pemphigus.
Topics: Adult; Azathioprine; Case-Control Studies; Female; Humans; Immunosuppressive Agents; Iran; Male; Mid | 2008 |
Tinea incognito hidden under apparently treatment-resistant pemphigus foliaceus.
Topics: Aged; Antifungal Agents; Azathioprine; Ciclopirox; Drug Resistance, Multiple; Female; Glucocorticoid | 2008 |
Tinea incognito hidden under apparently treatment-resistant pemphigus foliaceus.
Topics: Aged; Antifungal Agents; Azathioprine; Ciclopirox; Drug Resistance, Multiple; Female; Glucocorticoid | 2008 |
Juvenile pemphigus.
Topics: Adolescent; Adrenocorticotropic Hormone; Age Factors; Azathioprine; Child; Child, Preschool; Cortiso | 1983 |
Juvenile pemphigus.
Topics: Adolescent; Adrenocorticotropic Hormone; Age Factors; Azathioprine; Child; Child, Preschool; Cortiso | 1983 |
[Pemphigus herpetiformis].
Topics: Adult; Azathioprine; Biopsy; Drug Therapy, Combination; Fluorescent Antibody Technique; Humans; Male | 1984 |
[Pemphigus herpetiformis].
Topics: Adult; Azathioprine; Biopsy; Drug Therapy, Combination; Fluorescent Antibody Technique; Humans; Male | 1984 |
Juvenile pemphigus vulgaris.
Topics: Adolescent; Age Factors; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Humans; M | 1984 |
Juvenile pemphigus vulgaris.
Topics: Adolescent; Age Factors; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Humans; M | 1984 |
[Continuous plasma filtration. Experiences in the treatment of pemphigus vulgaris].
Topics: Adult; Autoantibodies; Azathioprine; Combined Modality Therapy; Complement System Proteins; Extracel | 1984 |
[Continuous plasma filtration. Experiences in the treatment of pemphigus vulgaris].
Topics: Adult; Autoantibodies; Azathioprine; Combined Modality Therapy; Complement System Proteins; Extracel | 1984 |
Persistent vegetating and keratotic lesions in patients with pemphigus vulgaris during immunosuppressive therapy.
Topics: Acantholysis; Aged; Azathioprine; Female; Humans; Immunosuppression Therapy; Keratosis; Male; Middle | 1983 |
Persistent vegetating and keratotic lesions in patients with pemphigus vulgaris during immunosuppressive therapy.
Topics: Acantholysis; Aged; Azathioprine; Female; Humans; Immunosuppression Therapy; Keratosis; Male; Middle | 1983 |
Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Pemphigus; Predni | 1984 |
Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Pemphigus; Predni | 1984 |
Azathioprine for use in dermatology.
Topics: Azathioprine; Behcet Syndrome; Humans; Pemphigoid, Bullous; Pemphigus; Pityriasis Rubra Pilaris; Pso | 1984 |
Azathioprine for use in dermatology.
Topics: Azathioprine; Behcet Syndrome; Humans; Pemphigoid, Bullous; Pemphigus; Pityriasis Rubra Pilaris; Pso | 1984 |
Pyodermite végétante of Hallopeau. Immunofluorescence studies performed in an early disease stage.
Topics: Animals; Azathioprine; Complement C3; Diagnosis, Differential; Epidermis; Female; Fluorescent Antibo | 1980 |
Pyodermite végétante of Hallopeau. Immunofluorescence studies performed in an early disease stage.
Topics: Animals; Azathioprine; Complement C3; Diagnosis, Differential; Epidermis; Female; Fluorescent Antibo | 1980 |
Acanthosis nigricans developing in resolving lesions of pemphigus vulgaris.
Topics: Acanthosis Nigricans; Adult; Azathioprine; Female; Humans; Pemphigus; Plasmapheresis; Prednisone | 1982 |
Acanthosis nigricans developing in resolving lesions of pemphigus vulgaris.
Topics: Acanthosis Nigricans; Adult; Azathioprine; Female; Humans; Pemphigus; Plasmapheresis; Prednisone | 1982 |
The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period.
Topics: Anti-Inflammatory Agents; Azathioprine; Drug Administration Schedule; Drug Therapy, Combination; Fol | 1995 |
The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period.
Topics: Anti-Inflammatory Agents; Azathioprine; Drug Administration Schedule; Drug Therapy, Combination; Fol | 1995 |
[Detection of an unusual varicella zoster virus infection in an immunosuppressed patient with polymerase chain reaction].
Topics: Acyclovir; Aged; Azathioprine; Chickenpox; Cytopathogenic Effect, Viral; Female; Herpesvirus 3, Huma | 1994 |
[Detection of an unusual varicella zoster virus infection in an immunosuppressed patient with polymerase chain reaction].
Topics: Acyclovir; Aged; Azathioprine; Chickenpox; Cytopathogenic Effect, Viral; Female; Herpesvirus 3, Huma | 1994 |
Azathioprine-induced drug fever.
Topics: Adult; Azathioprine; Female; Fever; Humans; Pemphigus | 1994 |
Azathioprine-induced drug fever.
Topics: Adult; Azathioprine; Female; Fever; Humans; Pemphigus | 1994 |
Pemphigus vulgaris precipitated by glibenclamide therapy.
Topics: Aged; Azathioprine; Candidiasis, Oral; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Fluconazole | 1993 |
Pemphigus vulgaris precipitated by glibenclamide therapy.
Topics: Aged; Azathioprine; Candidiasis, Oral; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Fluconazole | 1993 |
Paraneoplastic pemphigus in a patient with non-Hodgkin's lymphoma.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Combined Modality Thera | 1996 |
Paraneoplastic pemphigus in a patient with non-Hodgkin's lymphoma.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Combined Modality Thera | 1996 |
Minocycline is a useful adjuvant therapy for pemphigus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azathio | 1996 |
Minocycline is a useful adjuvant therapy for pemphigus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azathio | 1996 |
Thiopurine methyltransferase levels should be measured before commencing patients on azathioprine.
Topics: Azathioprine; Biomarkers; Contraindications; Humans; Male; Methyltransferases; Middle Aged; Neutrope | 1997 |
Thiopurine methyltransferase levels should be measured before commencing patients on azathioprine.
Topics: Azathioprine; Biomarkers; Contraindications; Humans; Male; Methyltransferases; Middle Aged; Neutrope | 1997 |
Azathioprine in dermatology: a survey of current practice in the U.K.
Topics: Azathioprine; Bone Marrow; Dermatitis, Atopic; Dermatology; Drug Administration Schedule; Health Car | 1997 |
Azathioprine in dermatology: a survey of current practice in the U.K.
Topics: Azathioprine; Bone Marrow; Dermatitis, Atopic; Dermatology; Drug Administration Schedule; Health Car | 1997 |
Invasive cutaneous aspergillosis complicating immunosuppressive therapy for recalcitrant pemphigus vulgaris.
Topics: Adult; Aspergillosis; Azathioprine; Cyclophosphamide; Cyclosporine; Dermatomycoses; Fatal Outcome; F | 1998 |
Invasive cutaneous aspergillosis complicating immunosuppressive therapy for recalcitrant pemphigus vulgaris.
Topics: Adult; Aspergillosis; Azathioprine; Cyclophosphamide; Cyclosporine; Dermatomycoses; Fatal Outcome; F | 1998 |
Mycophenolate is effective in the treatment of pemphigus vulgaris.
Topics: Adult; Azathioprine; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Humans; Immunosuppre | 1999 |
Mycophenolate is effective in the treatment of pemphigus vulgaris.
Topics: Adult; Azathioprine; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Humans; Immunosuppre | 1999 |
Paraneoplastic pemphigus as the presenting symptom of a lymphoma of the tongue.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Cyclop | 1998 |
Paraneoplastic pemphigus as the presenting symptom of a lymphoma of the tongue.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Cyclop | 1998 |
Childhood pemphigus.
Topics: Adolescent; Azathioprine; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; | 1999 |
Childhood pemphigus.
Topics: Adolescent; Azathioprine; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; | 1999 |
Pemphigus in Kuwait.
Topics: Age of Onset; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cushi | 1999 |
Pemphigus in Kuwait.
Topics: Age of Onset; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cushi | 1999 |
[Herpetic superinfection of pemphigus: 6 cases].
Topics: Acyclovir; Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Azathioprine; Cyclophosphamide; F | 1999 |
[Herpetic superinfection of pemphigus: 6 cases].
Topics: Acyclovir; Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Azathioprine; Cyclophosphamide; F | 1999 |
Oral pemphigus vulgaris preceding cutaneous lesions: recognition and diagnosis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Corneal Ulcer; Cyclophosphamide | 2000 |
Oral pemphigus vulgaris preceding cutaneous lesions: recognition and diagnosis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Corneal Ulcer; Cyclophosphamide | 2000 |
Photo quiz. Drug-induced pemphigus foliaceus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Stero | 2000 |
Photo quiz. Drug-induced pemphigus foliaceus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Stero | 2000 |
Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases.
Topics: Adult; Autoimmune Diseases; Azathioprine; Chronic Disease; Erythema; Female; Gels; Graft vs Host Dis | 2001 |
Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases.
Topics: Adult; Autoimmune Diseases; Azathioprine; Chronic Disease; Erythema; Female; Gels; Graft vs Host Dis | 2001 |
Cytomegalovirus-associated gastric ulcer in an immunosuppressed patient with pemphigus vulgaris.
Topics: Aged; Antiviral Agents; Azathioprine; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Immun | 2001 |
Cytomegalovirus-associated gastric ulcer in an immunosuppressed patient with pemphigus vulgaris.
Topics: Aged; Antiviral Agents; Azathioprine; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Immun | 2001 |
A case of pemphigus vulgaris possibly triggered by quinolones.
Topics: Aged; Azathioprine; Biopsy, Needle; Ciprofloxacin; Drug Therapy, Combination; Follow-Up Studies; Hum | 2002 |
A case of pemphigus vulgaris possibly triggered by quinolones.
Topics: Aged; Azathioprine; Biopsy, Needle; Ciprofloxacin; Drug Therapy, Combination; Follow-Up Studies; Hum | 2002 |
Two cases of penicillamine-induced pemphigus erythematosus.
Topics: Aged; Arthritis, Rheumatoid; Azathioprine; Drug Eruptions; Female; Humans; Middle Aged; Pemphigus; P | 1979 |
Two cases of penicillamine-induced pemphigus erythematosus.
Topics: Aged; Arthritis, Rheumatoid; Azathioprine; Drug Eruptions; Female; Humans; Middle Aged; Pemphigus; P | 1979 |
Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris.
Topics: Adult; Aged; Azathioprine; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; | 1978 |
Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris.
Topics: Adult; Aged; Azathioprine; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; | 1978 |
Lymphomatoid granulomatosis after immunosuppression for pemphigus.
Topics: Aged; Autopsy; Azathioprine; Granuloma; Humans; Immunosuppressive Agents; Lung; Lymphoma; Male; Pemp | 1978 |
Lymphomatoid granulomatosis after immunosuppression for pemphigus.
Topics: Aged; Autopsy; Azathioprine; Granuloma; Humans; Immunosuppressive Agents; Lung; Lymphoma; Male; Pemp | 1978 |
[Coexistence of pemphigus vulgaris and myopathy].
Topics: Azathioprine; Blepharoptosis; Female; Guanidines; Humans; Middle Aged; Pemphigus; Prednisolone | 1978 |
[Coexistence of pemphigus vulgaris and myopathy].
Topics: Azathioprine; Blepharoptosis; Female; Guanidines; Humans; Middle Aged; Pemphigus; Prednisolone | 1978 |
Pemphigus vulgaris.
Topics: Adolescent; Azathioprine; Female; Humans; Pemphigus; Prednisolone | 1978 |
Pemphigus vulgaris.
Topics: Adolescent; Azathioprine; Female; Humans; Pemphigus; Prednisolone | 1978 |
[Case of Behcet's syndrome].
Topics: Adult; Anti-Bacterial Agents; Arthritis, Reactive; Azathioprine; Behcet Syndrome; Cicatrix; Diagnosi | 1977 |
[Case of Behcet's syndrome].
Topics: Adult; Anti-Bacterial Agents; Arthritis, Reactive; Azathioprine; Behcet Syndrome; Cicatrix; Diagnosi | 1977 |
Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppre | 1977 |
Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppre | 1977 |
[Seborrhoic pemphigus].
Topics: Aged; Azathioprine; Candidiasis; Diabetes Mellitus; Female; Humans; Ointments; Pemphigus; Prednisolo | 1977 |
[Seborrhoic pemphigus].
Topics: Aged; Azathioprine; Candidiasis; Diabetes Mellitus; Female; Humans; Ointments; Pemphigus; Prednisolo | 1977 |
[Pemphigus--a model of modern dermatologic research].
Topics: Antibodies; Antigens; Azathioprine; Humans; Immunoglobulins; Immunosuppressive Agents; Pemphigus; Sk | 1976 |
[Pemphigus--a model of modern dermatologic research].
Topics: Antibodies; Antigens; Azathioprine; Humans; Immunoglobulins; Immunosuppressive Agents; Pemphigus; Sk | 1976 |
Pemphigus -- a review.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Autoimmune Diseases; Azathioprine; Blister; Cyclo | 1976 |
Pemphigus -- a review.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Autoimmune Diseases; Azathioprine; Blister; Cyclo | 1976 |
[Pemphigus and azathioprine].
Topics: Aged; Azathioprine; Diabetes Complications; Humans; Male; Pemphigus | 1975 |
[Pemphigus and azathioprine].
Topics: Aged; Azathioprine; Diabetes Complications; Humans; Male; Pemphigus | 1975 |
Visken as supplementary drug in the treatment of pemphigus.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Female; Humans; Male; Middle Aged; Pemphigus; Pindolol | 1975 |
Visken as supplementary drug in the treatment of pemphigus.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Female; Humans; Male; Middle Aged; Pemphigus; Pindolol | 1975 |
Pemphigus vulgaris and disseminated coccidioidomycosis.
Topics: Azathioprine; Betamethasone; Coccidioidomycosis; Humans; Immunosuppressive Agents; Male; Middle Aged | 1976 |
Pemphigus vulgaris and disseminated coccidioidomycosis.
Topics: Azathioprine; Betamethasone; Coccidioidomycosis; Humans; Immunosuppressive Agents; Male; Middle Aged | 1976 |
Pemphigus foliaceus. Use of antimalarial agents as adjuvant therapy.
Topics: Aged; Azathioprine; Chemotherapy, Adjuvant; Female; Humans; Hydroxychloroquine; Male; Middle Aged; P | 1992 |
Pemphigus foliaceus. Use of antimalarial agents as adjuvant therapy.
Topics: Aged; Azathioprine; Chemotherapy, Adjuvant; Female; Humans; Hydroxychloroquine; Male; Middle Aged; P | 1992 |
Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy.
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Female; Humans; Male; Middle Aged; Mouth Diseases; Pemp | 1992 |
Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy.
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Female; Humans; Male; Middle Aged; Mouth Diseases; Pemp | 1992 |
Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma.
Topics: Acanthosis Nigricans; Aged; Azathioprine; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Chronic | 1992 |
Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma.
Topics: Acanthosis Nigricans; Aged; Azathioprine; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Chronic | 1992 |
Diabetes mellitus induced in a dog after administration of corticosteroids and methylprednisolone pulse therapy.
Topics: Administration, Oral; Adrenal Cortex Hormones; Animals; Azathioprine; Dexamethasone; Diabetes Mellit | 1991 |
Diabetes mellitus induced in a dog after administration of corticosteroids and methylprednisolone pulse therapy.
Topics: Administration, Oral; Adrenal Cortex Hormones; Animals; Azathioprine; Dexamethasone; Diabetes Mellit | 1991 |
Childhood pemphigus foliaceus.
Topics: Azathioprine; Biopsy; Child; Female; Humans; Pemphigus; Prednisolone; Skin; Sulfapyridine | 1991 |
Childhood pemphigus foliaceus.
Topics: Azathioprine; Biopsy; Child; Female; Humans; Pemphigus; Prednisolone; Skin; Sulfapyridine | 1991 |
[Vulvovaginal and cervix uteri involvement disclosing pemphigus vulgaris. Efficacy of gold salt therapy].
Topics: Adult; Antirheumatic Agents; Azathioprine; Female; Humans; Organogold Compounds; Pemphigus; Predniso | 1990 |
[Vulvovaginal and cervix uteri involvement disclosing pemphigus vulgaris. Efficacy of gold salt therapy].
Topics: Adult; Antirheumatic Agents; Azathioprine; Female; Humans; Organogold Compounds; Pemphigus; Predniso | 1990 |
Oral pemphigus vulgaris in young adults.
Topics: Adult; Autoimmune Diseases; Azathioprine; Candidiasis, Oral; Female; Humans; Male; Mouth Diseases; P | 1991 |
Oral pemphigus vulgaris in young adults.
Topics: Adult; Autoimmune Diseases; Azathioprine; Candidiasis, Oral; Female; Humans; Male; Mouth Diseases; P | 1991 |
Pemphigus vulgaris of the oral mucosa: report of two cases.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Azathioprine; Female; Humans; Mouth Diseases; Mouth Muc | 1991 |
Pemphigus vulgaris of the oral mucosa: report of two cases.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Azathioprine; Female; Humans; Mouth Diseases; Mouth Muc | 1991 |
Immunosuppressive therapy of pemphigus vulgaris complicated by Nocardia pneumonia. Gold as an alternate therapy.
Topics: Azathioprine; Candidiasis; Female; Gold Sodium Thiomalate; Humans; Injections, Intramuscular; Middle | 1990 |
Immunosuppressive therapy of pemphigus vulgaris complicated by Nocardia pneumonia. Gold as an alternate therapy.
Topics: Azathioprine; Candidiasis; Female; Gold Sodium Thiomalate; Humans; Injections, Intramuscular; Middle | 1990 |
[A study on the therapy and prognosis of pemphigus vulgaris].
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Combined Modality Therapy; Female; Humans; Male; | 1990 |
[A study on the therapy and prognosis of pemphigus vulgaris].
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Combined Modality Therapy; Female; Humans; Male; | 1990 |
Immunosuppressive therapy for pemphigus vulgaris complicated by malakoplakia of the bladder.
Topics: Aged; Azathioprine; Escherichia coli Infections; Female; Humans; Immunosuppression Therapy; Malacopl | 1990 |
Immunosuppressive therapy for pemphigus vulgaris complicated by malakoplakia of the bladder.
Topics: Aged; Azathioprine; Escherichia coli Infections; Female; Humans; Immunosuppression Therapy; Malacopl | 1990 |
Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris.
Topics: Aged; Autoimmune Diseases; Azathioprine; Combined Modality Therapy; Drug Resistance; Female; Humans; | 1990 |
Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris.
Topics: Aged; Autoimmune Diseases; Azathioprine; Combined Modality Therapy; Drug Resistance; Female; Humans; | 1990 |
[Treatment of pemphigus with plasmapheresis].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Combined Modality Therapy; Humans; Male; Pemphigus; Pl | 1989 |
[Treatment of pemphigus with plasmapheresis].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Combined Modality Therapy; Humans; Male; Pemphigus; Pl | 1989 |
[Therapy of pemphigus. Critical remarks based on 44 clinical cases].
Topics: Adrenocorticotropic Hormone; Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; | 1985 |
[Therapy of pemphigus. Critical remarks based on 44 clinical cases].
Topics: Adrenocorticotropic Hormone; Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; | 1985 |
Pemphigus foliaceus--successful treatment with adjuvant gold therapy.
Topics: Azathioprine; Drug Therapy, Combination; Female; Gold Sodium Thiomalate; Humans; Middle Aged; Pemphi | 1987 |
Pemphigus foliaceus--successful treatment with adjuvant gold therapy.
Topics: Azathioprine; Drug Therapy, Combination; Female; Gold Sodium Thiomalate; Humans; Middle Aged; Pemphi | 1987 |
Porokeratosis and immunosuppressive treatment for pemphigus foliaceus.
Topics: Aged; Azathioprine; Female; Humans; Keratosis; Methylprednisolone; Pemphigus | 1988 |
Porokeratosis and immunosuppressive treatment for pemphigus foliaceus.
Topics: Aged; Azathioprine; Female; Humans; Keratosis; Methylprednisolone; Pemphigus | 1988 |
The course and prognosis of pemphigus. A review of 115 patients.
Topics: Adult; Age Factors; Azathioprine; Cause of Death; Drug Therapy, Combination; Female; Follow-Up Studi | 1988 |
The course and prognosis of pemphigus. A review of 115 patients.
Topics: Adult; Age Factors; Azathioprine; Cause of Death; Drug Therapy, Combination; Female; Follow-Up Studi | 1988 |
[Cazenave's pemphigus foliaceus: therapeutic difficulties. Aspects of transient acanthosis nigricans during healing].
Topics: Acanthosis Nigricans; Adult; Azathioprine; Cicatrix; Humans; Male; Pemphigus; Plasma Exchange | 1988 |
[Cazenave's pemphigus foliaceus: therapeutic difficulties. Aspects of transient acanthosis nigricans during healing].
Topics: Acanthosis Nigricans; Adult; Azathioprine; Cicatrix; Humans; Male; Pemphigus; Plasma Exchange | 1988 |
Pemphigus vulgaris. Combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine.
Topics: Adolescent; Antigen-Antibody Complex; Autoantibodies; Azathioprine; Combined Modality Therapy; Drug | 1988 |
Pemphigus vulgaris. Combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine.
Topics: Adolescent; Antigen-Antibody Complex; Autoantibodies; Azathioprine; Combined Modality Therapy; Drug | 1988 |
Oesophageal pemphigus vulgaris.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Esophageal Diseases; Esophagoscopy; Female; Humans; | 1988 |
Oesophageal pemphigus vulgaris.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Esophageal Diseases; Esophagoscopy; Female; Humans; | 1988 |
[Therapy of pemphigus and pemphigoid].
Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Humans; Methotrexate; Pemphigoid, Bullous | 1986 |
[Therapy of pemphigus and pemphigoid].
Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Humans; Methotrexate; Pemphigoid, Bullous | 1986 |
Metabolism of azathioprine to 6-thioguanine nucleotides in patients with pemphigus vulgaris.
Topics: Adult; Azathioprine; Female; Fluorescent Antibody Technique; Humans; Leukocyte Count; Male; Middle A | 1987 |
Metabolism of azathioprine to 6-thioguanine nucleotides in patients with pemphigus vulgaris.
Topics: Adult; Azathioprine; Female; Fluorescent Antibody Technique; Humans; Leukocyte Count; Male; Middle A | 1987 |
Neonatal pemphigus vulgaris: transplacental transmission of antibodies.
Topics: Adult; Azathioprine; Female; Fluorescent Antibody Technique; Humans; Immunity, Maternally-Acquired; | 1986 |
Neonatal pemphigus vulgaris: transplacental transmission of antibodies.
Topics: Adult; Azathioprine; Female; Fluorescent Antibody Technique; Humans; Immunity, Maternally-Acquired; | 1986 |
Use of cyclophosphamide in azathioprine failures in pemphigus.
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Dapsone; Drug Therapy, Combination; Female; Humans; Mal | 1987 |
Use of cyclophosphamide in azathioprine failures in pemphigus.
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Dapsone; Drug Therapy, Combination; Female; Humans; Mal | 1987 |
Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up.
Topics: Aged; Autoantibodies; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorti | 1987 |
Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up.
Topics: Aged; Autoantibodies; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorti | 1987 |
[Superficial pemphigus during the treatment of rheumatoid polyarthritis with D-penicillamine and piroxicam (Feldene)].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Azathioprine; Drug Therapy, Combination; H | 1985 |
[Superficial pemphigus during the treatment of rheumatoid polyarthritis with D-penicillamine and piroxicam (Feldene)].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Azathioprine; Drug Therapy, Combination; H | 1985 |
Azathioprine in pemphigus vulgaris.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Azathioprine; Drug Hypersensitivity; Female; Humans; Male; | 1970 |
Azathioprine in pemphigus vulgaris.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Azathioprine; Drug Hypersensitivity; Female; Humans; Male; | 1970 |
[Treatment of autoimmune diseases].
Topics: Adrenal Cortex Hormones; Aged; Anemia, Hemolytic, Autoimmune; Antilymphocyte Serum; Autoimmune Disea | 1971 |
[Treatment of autoimmune diseases].
Topics: Adrenal Cortex Hormones; Aged; Anemia, Hemolytic, Autoimmune; Antilymphocyte Serum; Autoimmune Disea | 1971 |
[Theoretical basis of immunosuppression in autoimmune diseases].
Topics: Antigens; Autoimmune Diseases; Azathioprine; Drug Synergism; Glucocorticoids; Humans; Immune Toleran | 1972 |
[Theoretical basis of immunosuppression in autoimmune diseases].
Topics: Antigens; Autoimmune Diseases; Azathioprine; Drug Synergism; Glucocorticoids; Humans; Immune Toleran | 1972 |
Pemphigus foliaceus.
Topics: Aged; Azathioprine; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Immunoglobulin M; Male | 1972 |
Pemphigus foliaceus.
Topics: Aged; Azathioprine; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Immunoglobulin M; Male | 1972 |
Pemphigus treatment with azathioprine. Clinical and immunologic correlation.
Topics: Adult; Aged; Antibodies; Azathioprine; Blood Platelets; Dose-Response Relationship, Drug; Fatigue; F | 1973 |
Pemphigus treatment with azathioprine. Clinical and immunologic correlation.
Topics: Adult; Aged; Antibodies; Azathioprine; Blood Platelets; Dose-Response Relationship, Drug; Fatigue; F | 1973 |
Coexistence of pemphigus and bullous pemphigoid.
Topics: Aged; Azathioprine; Biopsy; Diagnosis, Differential; Female; Fluorescent Antibody Technique; Humans; | 1974 |
Coexistence of pemphigus and bullous pemphigoid.
Topics: Aged; Azathioprine; Biopsy; Diagnosis, Differential; Female; Fluorescent Antibody Technique; Humans; | 1974 |
Pemphigus.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclophosphamide; Fluorescent Antibody Technique; Huma | 1974 |
Pemphigus.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclophosphamide; Fluorescent Antibody Technique; Huma | 1974 |
Azathioprine and pemphigus vulgaris.
Topics: Azathioprine; Female; Humans; Pemphigus | 1973 |
Azathioprine and pemphigus vulgaris.
Topics: Azathioprine; Female; Humans; Pemphigus | 1973 |
Treatment of pemphigus and pemphigoid with azathioprine.
Topics: Aged; Azathioprine; Candidiasis, Cutaneous; Drug Therapy, Combination; Female; Follow-Up Studies; Hu | 1973 |
Treatment of pemphigus and pemphigoid with azathioprine.
Topics: Aged; Azathioprine; Candidiasis, Cutaneous; Drug Therapy, Combination; Female; Follow-Up Studies; Hu | 1973 |
Azathioprine for pemphigus and pemphigoid--a 4 year follow-up.
Topics: Adult; Aged; Anemia; Azathioprine; Bone Neoplasms; Drug Evaluation; Drug Hypersensitivity; Female; F | 1974 |
Azathioprine for pemphigus and pemphigoid--a 4 year follow-up.
Topics: Adult; Aged; Anemia; Azathioprine; Bone Neoplasms; Drug Evaluation; Drug Hypersensitivity; Female; F | 1974 |
[Immunosuppressive therapy of pemphigus vulgaris. Preliminary results of azathioprine (Imuran) treatment)].
Topics: Adult; Aged; Azathioprine; Drug Synergism; Female; Glucocorticoids; Humans; Long-Term Care; Male; Mi | 1969 |
[Immunosuppressive therapy of pemphigus vulgaris. Preliminary results of azathioprine (Imuran) treatment)].
Topics: Adult; Aged; Azathioprine; Drug Synergism; Female; Glucocorticoids; Humans; Long-Term Care; Male; Mi | 1969 |
[Immunosuppressive therapy in pemphigus vulgaris].
Topics: Adult; Aged; Azathioprine; Desoxycorticosterone; Female; Humans; Immunosuppressive Agents; Male; Mer | 1970 |
[Immunosuppressive therapy in pemphigus vulgaris].
Topics: Adult; Aged; Azathioprine; Desoxycorticosterone; Female; Humans; Immunosuppressive Agents; Male; Mer | 1970 |
[Practical use of immunosuppressive and cytostatic drugs in dermatological diseases].
Topics: Antineoplastic Agents; Azathioprine; Condylomata Acuminata; Fluorouracil; Humans; Immunosuppressive | 1970 |
[Practical use of immunosuppressive and cytostatic drugs in dermatological diseases].
Topics: Antineoplastic Agents; Azathioprine; Condylomata Acuminata; Fluorouracil; Humans; Immunosuppressive | 1970 |
[Treatment of dermatologic lesions using immunosuppressive agents and cytostatics].
Topics: Antineoplastic Agents; Azathioprine; Dermatomyositis; Fluorouracil; Humans; Immunosuppressive Agents | 1970 |
[Treatment of dermatologic lesions using immunosuppressive agents and cytostatics].
Topics: Antineoplastic Agents; Azathioprine; Dermatomyositis; Fluorouracil; Humans; Immunosuppressive Agents | 1970 |
[Treatment of malignant pemphigus with azathiorpine].
Topics: Adult; Azathioprine; Female; Humans; Male; Middle Aged; Pemphigus; Prednisone | 1970 |
[Treatment of malignant pemphigus with azathiorpine].
Topics: Adult; Azathioprine; Female; Humans; Male; Middle Aged; Pemphigus; Prednisone | 1970 |
[Immunosuppressive agents and bullous diseases].
Topics: Adult; Aged; Autoantibodies; Azathioprine; Dermatitis Herpetiformis; Female; Glucocorticoids; Humans | 1970 |
[Immunosuppressive agents and bullous diseases].
Topics: Adult; Aged; Autoantibodies; Azathioprine; Dermatitis Herpetiformis; Female; Glucocorticoids; Humans | 1970 |
Pemphigus vulgaris.
Topics: Aged; Azathioprine; Female; Humans; Pemphigus; Prednisone | 1969 |
Pemphigus vulgaris.
Topics: Aged; Azathioprine; Female; Humans; Pemphigus; Prednisone | 1969 |